Trio Petroleum (TPET) 10-K/A 30 Jan 25 2024 FY Annual report (amended) Financial data

Cover

Cover - USD ($)	12 Months Ended
	Oct. 31, 2024	Jan. 29, 2025	Apr. 30, 2024
Cover [Abstract]
Document Type	10-K/A
Amendment Flag	true
Amendment Description	This amendment (the “Amendment”) is being filed to refile the financial statements of Trio Petroleum Corp. (the “Company”), including the notes to the financial statements, for the years ended October 31, 2024 and 2023, contained in the Annual Report on Form 10-K for the fiscal year ended October 31, 2024, filed with the Securities and Exchange Commission on January 17, 2025 (“Form 10-K), in order to replace the Report of Independent Registered Public Accounting Firm (“Auditor’s Report”) of Bush & Associates CPA LLC (“Bush”) with a corrected Auditor’s Report, which is included in the financial statements in this Amendment.Additionally, the Auditor’s Consent provided Bush as Exhibit 23.1 to the Form 10-K is also being replaced by a new Auditor’s Consent provided by Bush and filed as Exhibit 23.1 to this Amendment.  The Company’s Principal Executive and Principal Financial Officer has provided new certifications dated as of the date of this filing in connection with this Amendment (Exhibits 31.1, 31.2, 32.1 and 32.2).   Except as described above, no other portion of the Form 10-K is being amended and this Amendment does not reflect any events occurring after the filing of the Form 10-K.
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Oct. 31, 2024
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--10-31
Entity File Number	001-41643
Entity Registrant Name	TRIO PETROLEUM CORP.
Entity Central Index Key	0001898766
Entity Tax Identification Number	87-1968201
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	5401 Business Park South
Entity Address, Address Line Two	Suite 115
Entity Address, City or Town	Bakersfield
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	93309
City Area Code	(661)
Local Phone Number	324-3911
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	TPET
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 13,754,899
Entity Common Stock, Shares Outstanding		6,725,702
ICFR Auditor Attestation Flag	false
Document Financial Statement Error Correction [Flag]	false
Auditor Firm ID	5041
Auditor Name	Bush and Associates CPA LLC
Auditor Location	Henderson, Nevada

Balance Sheets

Balance Sheets - USD ($)	Oct. 31, 2024	Oct. 31, 2023
Current assets:
Cash	$ 285,945	$ 1,561,924
Prepaid expenses and other receivables	279,274	133,417
Total current assets	565,219	1,695,341
Oil and gas properties - not subject to amortization	11,119,119	9,947,742
Total assets	11,684,338	11,643,083
Current liabilities:
Accounts payable and accrued liabilities	1,036,291	609,360
Asset retirement obligations – current	2,778	2,778
Convertible note, net of discounts		1,217,597
Due to operators	103,146	21,651
Promissory notes, net of discounts	742,852
Other current liabilities	454,966
Total current liabilities	2,590,699	1,851,386
Long-term liabilities:
Asset retirement obligations, net of current portion	51,091	48,313
Total non-current liabilities	51,091	48,313
Total liabilities	2,641,790	1,899,699
Commitments and Contingencies (Note 8)
Stockholders’ Equity:
Preferred stock, $0.0001 par value; 500,000 shares authorized; -0- shares issued and outstanding at October 31, 2024 and 2023, respectively
Common stock, $0.0001 par value; 24,500,000 shares authorized; 3,203,068 and 1,552,328 shares issued and outstanding as of October 31, 2024 and 2023, respectively	320	155
Stock subscription receivable	(10,010)	(10,010)
Additional paid-in capital	29,125,917	20,200,121
Accumulated deficit	(20,073,679)	(10,446,882)
Total stockholders’ equity	9,042,548	9,743,384
Total liabilities and stockholders’ equity	11,684,338	11,643,083
Related Party [Member]
Current liabilities:
Note payable - related party	135,000
Payable – related party	$ 115,666

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - $ / shares	Oct. 31, 2024	Oct. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	24,500,000	24,500,000
Common stock, shares issued	3,203,068	1,552,328
Common stock, shares outstanding	3,203,068	1,552,328

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Income Statement [Abstract]
Revenue	$ 213,204
Operating expenses:
Exploration expense	177,416	251,743
General and administrative expenses	4,716,057	3,315,782
Stock-based compensation expense	1,534,667	1,044,261
Accretion expense	2,778	2,778
Total operating expenses	6,430,918	4,614,564
Loss from operations	(6,217,714)	(4,614,564)
Other expenses:
Interest expense	2,118,548	791,811
Loss on settlement		13,051
Loss on note conversion	1,290,535	1,125,000
Total other expenses	3,409,083	1,929,862
Loss before income taxes	(9,626,797)	(6,544,426)
Provision for income taxes
Net loss	$ (9,626,797)	$ (6,544,426)
Basic and Diluted Net Loss per Common Share
Basic	$ (4.32)	$ (5.67)
Diluted	$ (4.32)	$ (5.67)
Weighted Average Number of Common Shares Outstanding
Basic	2,226,320	1,153,988
Diluted	2,226,320	1,153,988

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Share Subscription Receivables [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Oct. 31, 2022	$ 85	$ (10,010)	$ 6,635,505	$ (3,902,456)	$ 2,723,124
Balance, shares at Oct. 31, 2022	848,640
Issuance of equity warrants in connection with convertible debt (Tranche #1)			332,630		332,630
Issuance of commitment shares related to the January 2022 SPA	$ 2		1,124,998		1,125,000
Issuance of commitment shares related to the January 2022 SPA, shares	18,750
Stock-based compensation	$ 1		1,044,261		1,044,261
Net loss				(6,544,426)	(6,544,426)
Issuance of common stock for cash, net	$ 2		371,998		372,000
Issuance of common stock for cash, net, shares	20,000
Issuance of conversion shares related to the January 2022 SPA	$ 25		5,164,850		5,164,875
Issuance of conversion shares related to the January 2022 SPA, shares	251,946
Issuance of common shares in IPO, net of underwriting discounts and offering costs	$ 10		3,342,616		3,342,626
Issuance of common shares in IPO, net of underwriting discounts and offering costs, shares	100,000
Issuance of pre-funded warrants			4,000		4,000
Issuance of common stock upon exercise of warrants, net	$ 12		1,812,623		1,812,635
Issuance of common stock upon exercise of warrants, net, shares	122,474
Issuance of common stock for services, net	$ 1		366,658		366,659
Issuance of common stock for services, net, shares	14,275
Issuance of restricted stock units under the Equity Incentive Plan	$ 11		(12)
Issuance of restricted stock units under the Equity Incentive Plan, shares	106,250
Issuance of common stock for warrants that can be exercised per the Resale S-1/A	$ 6		(6)
Issuance of common stock for warrants that can be exercised per the Resale S-1/A, shares	59,993
Stock-based compensation, shares	10,000
Balance at Oct. 31, 2023	$ 155	(10,010)	20,200,121	(10,446,882)	9,743,384
Balance, shares at Oct. 31, 2023	1,552,328
Issuance of common shares in lieu of cash payments on convertible notes	$ 82		3,323,505		3,323,587
Issuance of common shares in lieu of cash payments, shares	816,681
Issuance of common shares in lieu of cash payments on promissory notes	$ 31		1,079,006		1,079,037
Issuance of common shares in lieu of cash payments, shares	312,441
Issuance of common shares to consultants	$ 11		738,289		738,300
Issuance of common shares to consultants, shares	107,500
Issuance of equity warrants in connection with convertible debt (Tranche #1)			409,191		409,191
Issuance of commitment shares related to the January 2022 SPA	$ 8		667,492		667,500
Issuance of commitment shares related to the January 2022 SPA, shares	75,000
Adjustment to common stock for warrants related to Resale S-1/A	$ (3)		3
Adjustment to common stock for warrants related to resale S-1/A, shares	(22,590)
Issuance of common shares related to ATM agreement, net	$ 36		1,173,643		1,173,679
Issuance of common shares related to ATM, shares	361,708
Stock-based compensation			1,534,667		1,534,667
Net loss				(9,626,797)	(9,626,797)
Balance at Oct. 31, 2024	$ 320	$ (10,010)	$ 29,125,917	$ (20,073,679)	$ 9,042,548
Balance, shares at Oct. 31, 2024	3,203,068

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (9,626,797)	$ (6,544,426)
Adjustments to reconcile net loss to net cash used in operating activities:
Franchise tax fees		(9,450)
Bad debt expense		25,000
Accretion expense	2,778	2,778
Conversion of January 2022 SPA		1,125,000
Debt discount - OID	(347,968)	(140,000)
Amortization of debt discounts	2,092,671	473,240
Write-off of January 2022 SPA receivable
Issuance of common shares for services	738,300
Stock-based compensation	1,534,667	1,044,261
Loss on issuance of common shares in lieu of cash for debt payments	1,022,534
Changes in operating assets and liabilities:
Prepaid expenses and other receivables	(145,857)	(123,417)
Other current liabilities	454,966
Accounts payable and accrued liabilities	433,962	110,180
Net cash used in operating activities	(3,840,744)	(4,036,834)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for unproved oil and gas properties	(1,171,377)	(362,022)
Drilling costs for exploratory well		(3,749,488)
Advances to operators		1,900,000
Due to operators	81,495	21,651
Net cash used in investing activities	(1,089,882)	(2,189,859)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net		738,659
Proceeds from notes payable, related parties	250,666
Proceeds from convertible debt	550,000	2,000,000
Proceeds from promissory notes	2,292,972
Proceeds from issuance of common shares related to ATM agreement	1,173,679
Proceeds from issuance of common shares related to IPO		6,000,000
Proceeds from exercise of warrants, net		1,812,635
Repayment of debt	(352,767)	(1,472,512)
Payments for debt issuance costs	(259,903)	(350,320)
Payments for deferred offering costs		(1,013,493)
Net cash provided by financing activities	3,654,647	7,714,969
NET CHANGE IN CASH	(1,275,979)	1,488,276
Cash - Beginning of period	1,561,924	73,648
Cash - End of period	285,945	1,561,924
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities:
Issuance of warrants	$ 409,191	$ 332,630
Issuance of RSUs	911,650	213
Issuance of commitment shares	$ 667,500
Issuance of common stock for warrants that can be exercised per the Resale S-1/A		120
Issuance of pre-funded warrants		$ 4,000

NATURE OF THE ORGANIZATION AND

NATURE OF THE ORGANIZATION AND BUSINESS	12 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF THE ORGANIZATION AND BUSINESS	NOTE 1 – NATURE OF THE ORGANIZATION AND BUSINESS Company Organization Trio Petroleum Corp. (“Trio Petroleum”, the “Company” or “TPET”) is a California-based oil and gas exploration and development company headquartered in Bakersfield, California, with its principal executive offices located at 5401 Business Park South, Suite 115, Bakersfield, California 93309, and with operations in Monterey County, California, and Uintah County, Utah. The Company was incorporated on July 19, 2021, under the laws of Delaware to acquire, fund, and operate oil and gas exploration, development and production projects, initially focusing on one major asset in California, the South Salinas Project (“South Salinas Project”). The Company has since acquired interests in the McCool Ranch Oil Field in Monterey County, California, and in the Asphalt Ridge Project in Uintah County, Utah. The Company has had revenue-generating operations since the McCool Ranch Oil Field was restarted on February 22, 2024, and recognized its first revenues in the fiscal quarter ended April 30, 2024, and received the proceeds from these operations in June 2024. Acquisition of South Salinas Project The Company was initially formed to acquire from Trio Petroleum LLC (“Trio LLC”) an approximate 82.75 85.775 9,300 300,000 3,700,000 245,000 0.0001 45 Business Combinations 68.62 3.8 There are two contiguous areas of notable oil/gas accumulations in the South Salinas Project; the first is the Humpback Area that occurs in the northern part of the project and the second is the Presidents Area (“Presidents Oil Field”) that occurs in the southern part of the project. As October 31, 2024 and 2023, there were no proved reserves attributable to the approximate 9,300 Initial Public Offering The Company’s Registration Statement (Amendment No. 9) on Form S-1/A was filed with the SEC on March 24, 2023; its Initial Public Offering was declared effective on April 17, 2023 and closed on April 20, 2023 (collectively, the “Offering” or “IPO”). The Company sold 100,000 6,000,000 Additional Acquisitions - McCool Ranch Oil Field & Asphalt Ridge Leasehold In October 2023, the Company entered into an agreement (“McCool Ranch Purchase Agreement”) with Trio LLC for purchase of a 21.918315 November 2023, the Company entered into a leasehold acquisition and development option agreement (“ARLO Agreement”) with Heavy Sweet Oil, LLC (“HSO”), which gave the Company a 9-month option for the exclusive right to acquire up to a 20 960 2,000,000 200,000 2 25,000 2.25 1.775 17.75 Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”). Use of Estimates The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transaction and disclosure of contingent assets and liabilities at the date of the financial statements, and the revenue and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates required to be made by management include estimates of oil and natural gas reserves (when and if assigned) and related present value estimates of future net cash flows therefrom, the carrying value of oil and natural gas properties, ARO and the valuation of equity-based transactions. Accordingly, actual results could differ significantly from those estimates. Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no Prepaid Expenses Prepaid expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of October 31, 2024 and 2023, the balances of the prepaids account were $ 279,274 133,417 Debt Issuance Costs Costs incurred in connection with the issuance of the Company’s debt have been recorded as a direct reduction against the debt and amortized over the life of the associated debt as a component of interest expense. As of October 31, 2024 and 2023, the Company recorded $ 259,903 350,320 Oil and Gas Assets and Exploration Costs – Successful Efforts The Company’s projects are in exploration and/or early production stages and the Company began generating revenue from its operations during the quarterly period ended April 30, 2024. It applies the successful efforts method of accounting for crude oil and natural gas properties. Under this method, exploration costs such as exploratory, geological, and geophysical costs, delay rentals and exploratory overhead are expensed as incurred. If an exploratory property provides evidence to justify potential development of reserves, drilling costs associated with the property are initially capitalized, or suspended, pending a determination as to whether a commercially sufficient quantity of proved reserves can be attributed to the area as a result of drilling. At the end of each quarter, management reviews the status of all suspended exploratory property costs considering ongoing exploration activities; in particular, whether the Company is making sufficient progress in its ongoing exploration and appraisal efforts. If management determines that future appraisal drilling or development activities are unlikely to occur, associated exploratory well costs are expensed. Costs to acquire mineral interests in crude oil and/or natural gas properties, drill and equip exploratory wells that find proved reserves and drill and equip development wells are capitalized. Acquisition costs of unproved leaseholds are assessed for impairment during the holding period and transferred to proven crude oil and/or natural gas properties to the extent associated with successful exploration activities. Significant undeveloped leases are assessed individually for impairment, based on the Company’s current exploration plans, and a valuation allowance is provided if impairment is indicated. Capitalized costs from successful exploration and development activities associated with producing crude oil and/or natural gas leases, along with capitalized costs for support equipment and facilities, are amortized to expense using the unit-of-production method based on proved crude oil and/or natural gas reserves on a field-by-field basis, as estimated by qualified petroleum engineers. The Company currently has four wells that are producing (one well in President’s Field in the South Salinas Project and three wells at the McCool Ranch Oil Field) and is evaluating the impact of production on the reserve determination for those wells and fields. The Company expects to add the reserve value of such fields to the Company’s reserve report after a further period of observation and review of the oil production. As of October 31, 2024 and 2023, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization. Unproved oil and natural gas properties Unproved oil and natural gas properties have unproved lease acquisition costs, which are capitalized until the lease expires or otherwise until the Company specifically identifies a lease that will revert to the lessor, at which time the Company charges the associated unproved lease acquisition costs to exploration costs. Unproved oil and natural gas properties are not subject to amortization and are assessed periodically for impairment on a property-by-property basis based on remaining lease terms, drilling results or future plans to develop acreage. The Company currently has four wells that are producing (one well in President’s Field in the South Salinas Project and three wells at the McCool Ranch Oil Field) and is evaluating the impact of production on the reserve determination for those wells and fields. The Company expects to add the reserve value of such fields to the Company’s reserve report after a further period of observation and review of the oil production. As of October 31, 2024 and 2023, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization; see further discussion in Note 6. Impairment of Other Long-lived Assets The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of the asset by estimating the future net undiscounted cash flows expected to result from the asset, including eventual disposition. If the future net undiscounted cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and estimated fair value. With regards to oil and gas properties, this assessment applies to proved properties . As of October 31, 2024 and 2023, the Company had no Asset Retirement Obligations ARO consists of future plugging and abandonment expenses on oil and natural gas properties. In connection with the South Salinas Project (“SSP”) acquisition described above, the Company acquired the plugging and abandonment liabilities associated with six non-producing wells. The fair value of the ARO was recorded as a liability in the period in which the wells were acquired with a corresponding increase in the carrying amount of oil and natural gas properties not subject to impairment. The Company plans to utilize the six wellbores acquired in the SSP acquisition in future exploration, production and/or disposal (i.e., disposal of produced water or CO2 by injection) activities. The liability is accreted for the change in its present value each period based on the expected dates that the wellbores will be required to be plugged and abandoned. The capitalized cost of ARO is included in oil and gas properties and is a component of oil and gas property costs for purposes of impairment and, if proved reserves are found, such capitalized costs will be depreciated using the units-of-production method. The asset and liability are adjusted for changes resulting from revisions to the timing or the amount of the original estimate when deemed necessary. If the liability is settled for an amount other than the recorded amount, a gain or loss is recognized. Components of the changes in ARO for the years ended October 31, 2023 and 2024 are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO ARO, ending balance – October 31, 2022 $ 48,313 Accretion expense 2,778 ARO, ending balance – October 31, 2023 51,091 Accretion expense 2,778 ARO, ending balance – October 31, 2024 53,869 Less: ARO – current 2,778 ARO, net of current portion – October 31, 2024 $ 51,091 Related Parties Related parties are directly or indirectly related to the Company, through one or more intermediaries and are in control, controlled by, or under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. On September 14, 2021, the Company acquired an 82.75 85.775 245,000 45 1 1 Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company utilizes ASC 740, Income Taxes For uncertain tax positions that meet a “more likely than not” threshold, the Company recognizes the benefit of uncertain tax positions in the financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the statements of operations when a determination is made that such expense is likely. The Company is subject to income tax examinations by major taxing authorities since inception. Fair Value Measurements The carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement. As defined in ASC 820, Fair Value Measurements and Disclosures Level 1: Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Level Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. Level Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques. There are no assets or liabilities measured at fair value on a recurring basis. Assets and liabilities accounted for at fair value on a non-recurring basis in accordance with the fair value hierarchy include the initial allocation of the asset acquisition purchase price, including asset retirement obligations, the fair value of oil and natural gas properties and the assessment of impairment. The fair value measurements and allocation of assets acquired are measured on a nonrecurring basis on the acquisition date using an income valuation technique based on inputs that are not observable in the market and therefore represent Level 3 inputs. Significant inputs used to determine the fair value include estimates of: (i) reserves; (ii) future commodity prices; (iii) operating and development costs; and (iv) a market-based weighted average cost of capital rate. The underlying commodity prices embedded in the Company’s estimated cash flows are the product of a process that begins with NYMEX forward curve pricing, adjusted for estimated location and quality differentials, as well as other factors that the Company’s management believes will impact realizable prices. These inputs require significant judgments and estimates by the Company’s management at the time of the valuation. The fair value of additions to the asset retirement obligation liabilities is measured using valuation techniques consistent with the income approach, which converts future cash flows to a single discounted amount. Significant inputs to the valuation include: (i) estimated plug and abandonment cost per well for all oil and natural gas wells and for all disposal wells; (ii) estimated remaining life per well; (iii) future inflation factors; and (iv) the Company’s average credit-adjusted risk-free rate. These assumptions represent Level 3 inputs. If the carrying amount of its proved oil and natural gas properties, which are assessed for impairment under ASC 360 – Property, Plant and Equipment, Net Loss Per Share Basic and diluted net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similar to basic loss per share, except the weighted average number of common shares outstanding are increased to include additional shares from the assumed exercise of share options, warrants and convertible notes, if dilutive. The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been anti-dilutive: SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI_DILUTIVE As of October 31, As of October 31, 2024 2023 Warrants 19,176 (1) 19,812 (2) Total potentially dilutive securities 19,176 19,812 (1) Balance consists of potentially dilutive shares based on 191,994 88,336 (2) Balance consists of restricted stock units granted to five outside directors and restricted shares issued to executives. Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time to varying degrees by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company’s policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries. Recent Accounting Pronouncements All recently issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company. Reclassification of Expenses Certain amounts in the prior periods presented have been reclassified to the current period financial statement presentation. This reclassification has no effect on previously reported net income. Subsequent Events The Company evaluated all events and transactions that occurred after October 31, 2024 through the date of the filing of this report. See Note 12 for such events and transactions.

GOING CONCERN AND MANAGEMENT_S

GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS	12 Months Ended
	Oct. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS	NOTE 3 – GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS As of October 31, 2024, the Company had $ 285,945 2,025,480 2,371,500 125,000 184,500 720,000 720,000 359,000 1,174,000 The accompanying financial statements have been prepared on the basis that the Company will continue as a going concern over the next twelve months from the date of issuance of these financial statements, which assumes the realization of assets and the satisfaction of liabilities in the normal course of business. As of October 31, 2024, the Company has an accumulated deficit of $ 20,073,679 Accordingly, the accompanying financial statements have been prepared in conformity with U.S. GAAP, which contemplates continuation of the Company as a going concern and the realization of assets and the satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	12 Months Ended
	Oct. 31, 2024
Initial Public Offering
INITIAL PUBLIC OFFERING	NOTE 4 – INITIAL PUBLIC OFFERING The Company’s Registration Statement (Amendment No. 9) on Form S-1/A was filed with the SEC on March 24, 2023; its Initial Public Offering was declared effective on April 17, 2023 and closed on April 20, 2023 (collectively, the “Offering” or “IPO”). The Company sold 100,000 60.00 6,000,000 4,940,000 5,000 66.00 110

REVENUE FROM CONTRACTS WITH CUS

REVENUE FROM CONTRACTS WITH CUSTOMERS	12 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
REVENUE FROM CONTRACTS WITH CUSTOMERS	NOTE 5 – REVENUE FROM CONTRACTS WITH CUSTOMERS Disaggregation of Revenue from Contracts with Customers The following table disaggregates revenue by significant product type for the periods below: SCHEDULE OF DISAGGREGATES REVENUE As of October 31, As of October 31, 2024 2023 Oil sales $ 213,204 $ - Total revenues from customers $ 213,204 $ - There were no no Significant concentrations of credit risk For the year ended October 31, 2024 ( no 10

OIL AND NATURAL GAS PROPERTIES

OIL AND NATURAL GAS PROPERTIES	12 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
OIL AND NATURAL GAS PROPERTIES	NOTE 6 – OIL AND NATURAL GAS PROPERTIES The following tables summarize the Company’s oil and gas activities. SCHEDULE OF OIL AND NATURAL GAS PROPERTIES As of October 31, As of October 31, 2024 2023 Oil and gas properties – not subject to amortization $ 11,119,119 $ 9,947,742 Accumulated impairment — — Oil and gas properties – not subject to amortization, net $ 11,119,119 $ 9,947,742 During the years ended October 31, 2024 and 2023, the Company incurred aggregated exploration costs of $ 177,416 251,743 1.2 4.1 Leases South Salinas Project As of October 31, 2024, the Company holds interests in various leases related to the unproved properties of the South Salinas Project (see Note 8); two of the leases are held with the same lessor. The first lease, which covers 8,417 252,512 The second lease covers 160 30 During February and March of 2023, the Company entered into additional leases related to the unproved properties of the South Salinas Project with two groups of lessors. The first group of leases covers 360 20 25 307.75 20 30 McCool Ranch Oil Field In October 2023, the Company entered into the McCool Ranch Purchase Agreement with Trio LLC for purchase of a 21.918315 100,000 400,000 284,000 116,000 The Company holds interests in various leases related to the unproved properties of the McCool Ranch Oil Field; these leases occur in two parcels, “Parcel 1” and “Parcel 2”. Parcel 1 comprises ten leases and approximately 480 320 800 Optioned Assets – Old Man Prospect In October 2023, the Company and Lantos Energy entered into an option agreement, whereby the Company has the option to pay two initial payments of $ 12,500 175,000 200,000 the effective date for exclusive rights to the option to purchase 80% of the 100% Before Project Payout Working Interest 25,000 175,000 Optioned Assets – Asphalt Ridge Leasehold Acquisition & Development Option Agreement On November 10, 2023, the Company entered into the ARLO Agreement with HSO for a term of nine months which gives the Company the exclusive right to acquire up to a 20 960 2,000,000 500,000 On December 29, 2023, the Company entered into an amendment to the ARLO Agreement, whereby the Company funded $ 200,000 500,000 2 225,000 2.25 Per the most recent amendment to the ARLO Agreement signed in September 2024, the Company has until December 10, 2024 to pay HSO an additional $ 1,775,000 17.75 960 1,775,000 17.75 17.75 960

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Oct. 31, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 7 – RELATED PARTY TRANSACTIONS South Salinas Project – Related Party Upon its formation, the Company acquired from Trio LLC a majority working interest in the South Salinas Project and engaged the services of certain members of Trio LLC to manage the Company’s assets (see Note 1 and Note 6). Trio LLC operates the South Salinas Project on behalf of the Company, and as operator, conducts and has full control of the operations within the constraints of the Joint Operating Agreement, and acts in the capacity of an independent contractor. Trio LLC currently holds a 3.8 85.775 128,200 21,651 McCool Ranch Oil Field Asset Purchase – Related Party On October 16, 2023, the Company entered into the McCool Ranch Purchase Agreement with Trio LLC for purchase of a 21.918315 100,000 400,000 284,000 116,000 Restricted Stock Units (“RSUs”) issued to Directors Pursuant to the 2022 Equity Incentive Plan (“the Plan”), on September 2, 2023, the Company issued an aggregate 21,250 0.0001 12.80 273,275 On June 19, 2024, the Company agreed to award 50,000 22,750 22,500 6.00 134,550 25 27,500 3.32 91,300 30,651 0 195,199 On October 21, 2024, the Company agreed to award 12,500 100 3.13 39,125 37,500 100 3.13 117,375 14,908 0 141,592 Restricted Shares issued to Executives and Employees In February 2022, the Company entered into employment agreements with Frank Ingriselli (former Chief Executive Officer) and Greg Overholtzer (Chief Financial Officer or “CFO”) which, among other things, provided for the grant of restricted shares in the amounts of 50,000 5,000 25 5.88 55,000 323,400 155,498 161,700 In May 2023, the Company entered into six employee agreements which, among other things, provided for the grant of an aggregate of 35,000 25 43.00 1,505,000 753,188 440,219 311,593 On October 16, 2023, the Company and Michael L. Peterson entered into an employment agreement (the “Peterson Employment Agreement”), effective as of October 23, 2023, pursuant to which Mr. Peterson will serve as Chief Executive Officer of the Company, replacing Mr. Ingriselli. Pursuant to the Peterson Employment Agreement, Mr. Peterson will be paid an annual base salary of $ 350,000 100 Pursuant to the Peterson Employment Agreement, the Company issued Mr. Peterson a grant of 50,000 5.40 271,000 25 125,000 125,000 50,000 267,659 3,341 On the same date as Mr. Peterson’s resignation as the Company’s Chief Executive Officer on July 11, 2024, the Company and Mr. Peterson entered into a three-month consulting agreement, which includes a monthly cash fee of $ 10,000 50,000 3.32 166,000 97,967 0 68,033 On July 11, 2024, the Company entered into an employment agreement with Mr. Robin Ross, pursuant to which Mr. Ross will serve as Chief Executive Officer of the Company, replacing Mr. Peterson. Pursuant to the Ross Employment Agreement, Mr. Ross will be paid an annual base salary of $ 300,000 100 100,000 25 3.32 332,000 21,890 0 310,110 On October 21, 2024, the Company agreed to award 10,000 100 3.13 31,300 1,720 0 29,580 Note Payable – Related Party On March 26, 2024, the Company borrowed $ 125,000 125,000 10 1,000,000 50,000 On September 26, 2024 and October 28, 2024, the Company entered into the first and second amendments, respectively, to the Peterson Note; each amendment extended the maturity dates to October 28, 2024 and November 30, 2024, respectively, and added a $ 5,000 135,000

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Oct. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 – COMMITMENTS AND CONTINGENCIES From time to time, the Company is subject to various claims that arise in the ordinary course of business. Management believes that any liability of the Company that may arise out of or with respect to these matters will not materially adversely affect the financial position, results of operations, or cash flows of the Company. Unproved Property Leases The Company holds interests in various leases related to the unproved properties of the South Salinas Project (see Note 6); two of the leases are held with the same lessor. The first lease, which covers 8,417 252,512 The second lease covers 160 30 The Company holds interests in various leases related to the unproved properties of the McCool Ranch Oil Field. These leases occur in two parcels, “Parcel 1” and “Parcel 2”. Parcel 1 comprises ten leases and approximately 480 320 800 During February and March of 2023, the Company entered into additional leases related to the unproved properties of the South Salinas Project with two groups of lessors. The first group of leases covers 360 20 25 307.75 20 30 On November 10, 2023, the Company entered into the ARLO Agreement with HSO for a term of nine months which allows the Company the exclusive right to acquire up to a 20 960 2,000,000 500,000 On December 29, 2023, the Company entered into an amendment to the ARLO Agreement, whereby the Company funded $ 200,000 500,000 2 225,000 2.25 Per the most recent amendment to the ARLO Agreement signed in September 2024, the Company has until December 10, 2024 to pay HSO an additional $ 1,775,000 17.75 960 1,775,000 17.75 17.75 960 Board of Directors Compensation On July 11, 2022, the Company’s Board of Directors approved compensation for each of the non-employee directors of the Company, which would be effective upon the consummation of the IPO. Such compensation is structured as follows: an annual retainer of $ 50,000 10,000 223,170 156,154 Agreements with Advisors On July 28, 2022, the Company entered into a placement agent agreement with the Placement Agent with Spartan Capital Securities, LLC (“Spartan”), whereby Spartan agreed to serve as the exclusive agent, advisor or underwriter in any offering of securities of the Company for a one-year term. The agreement provided for a $ 25,000 the Company’s initial public offering (“IPO”), a cash fee of 7.5%, warrants to purchase a number of common shares equal to 5% of the aggregate number of common shares placed in the IPO and reimbursement of other expenses. 5,000 five-year 66.00 On October 4, 2023 and December 29, 2023, the Company entered into additional placement agent agreements with Spartan, whereby Spartan would serve as the exclusive placement agent in connection with the closing of private placements. The agreements provided the agent with i) a cash fee 7.5% of the aggregate proceeds raised in the sale and ii) warrants to purchase a number of common shares equal to 5% of the number of common shares initially issuable upon conversion of each note tranche; warrants to purchase 4,167 2,750 26.40 11.00 Compliance with NYSE American On February 26, 2024, the Company received written notice from the NYSE American LLC (“NYSE American”) indicating that the Company is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (“Section 1003(f)(v)”) because the shares of the Company’s common stock, par value $ 0.0001 Pursuant to Section 1003(f)(v), the NYSE American staff (the “Staff”) determined that the Company’s continued listing is predicated on effecting a reverse stock split of its Common Stock or demonstrating sustained price improvement within a reasonable period of time, which the Staff determined to be no later than August 26, 2024. On May 1, 2024, the NYSE American notified the Company that it had regained compliance with the NYSE American listing requirements with respect to Section 1003(f)(v) of the NYSE American Company Guide due to its shares of common stock demonstrating sustained price improvement.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 9 – INCOME TAXES The Company accounts for income taxes under ASC 740-10, which provides for an asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributed to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes. Significant components of the Company’s deferred tax assets are summarized below. SCHEDULE OF DEFERRED TAX ASSETS As of October 31, As of October 31, 2024 2023 Deferred tax assets: Net operating loss carry forwards $ 1,699,000 $ 1,095,000 Total deferred tax asset 1,699,000 1,095,000 Valuation allowance (1,699,000 ) (1,095,000 ) Deferred tax asset, net $ - $ - As of October 31, 2024 and 2023, the Company had approximately $ 1,699,000 1,095,000 The Company recorded a valuation allowance in the full amount of its net deferred tax assets since realization of such tax benefits has been determined by the Company’s management to be less likely than not. The valuation allowance increased $ 604,000 298,000 A reconciliation of the statutory federal income tax benefit to actual tax benefit is as follows: SCHEDULE OF EFFECTIVE FEDERAL INCOME TAX RATE RECONCILIATION As of October 31, As of October 31, 2024 2023 Federal statutory blended income tax rates (21 )% (21 )% State statutory income tax rate, net of federal benefit - % - % Change in valuation allowance 21 % 21 % Effective tax rate - % - % As of the date of this filing, the Company has not filed its 2024 federal and state corporate income tax returns. The Company expects to file these documents as soon as practicable. The Company has evaluated its income tax positions and has determined that it does not have any uncertain tax positions. The Company will recognize interest and penalties related to any uncertain tax positions through its income tax expense.

NOTES PAYABLE

NOTES PAYABLE	12 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
NOTES PAYABLE	NOTE 10 – NOTES PAYABLE Notes payable as of October 31, 2024 and 2023 consisted of the following: SCHEDULE OF NOTES PAYABLE As of As of October 31, 2024 October 31, 2023 Convertible note, net of discounts $ - $ 1,217,597 Promissory notes, net of discounts 742,852 - Note payable – related party 135,000 - Total Notes payable $ 877,852 $ 1,217,597 Convertible note, net of discounts (October 2023 SPA) On October 4, 2023, the Company entered into a securities purchase agreement (the “October 2023 SPA”) with an investor; the October 2023 SPA provides for loans in an aggregate principal amount of up to $ 3.5 2.0 1.5 In consideration for the investor’s funding of the first tranche, the Company issued i) a senior secured convertible promissory note in the aggregate principal amount of $ 2,000,000 43,336 24.00 24.00 7.00 Upon the initial funding on October 4, 2023, the Company recorded gross proceeds of approximately $ 2.0 7 140,000 350,320 1.5 43,336 332,630 11.00 24.00 5 137.10 zero 4.72 On December 18, 2023, December 29, 2023 and January 12, 2024, the Company made principal payments towards the first tranche in the amounts of $ 125,000 125,000 125,000 103 128,750 128,750 128,750 18,393 18,393 18,393 6.80 6.20 5.80 125,072 114,036 105,575 36,698 35,837 49,935 36,770 24,873 30,510 On December 29, 2023, the Company entered into an amendment to the Second Tranche Note of the October 2023 SPA, which reduced the conversion price of note and exercise price of warrant from $ 24.00 10.00 To assess for the change in relative fair value, the Company performed a Black Scholes Option Model calculation to quantify the fair value of the common warrants under their original terms as of the modification date using the following assumptions: a share price of $ 6.20 24.00 5.0 137.1 0 3.84 6.20 10.00 5.0 137.1 0 3.84 0.1 On January 2, 2024, the second tranche of the October 2023 SPA was funded, and the Company recorded gross proceeds of approximately $ 550,000 7 38,500 90,978 421,000 22,279 98,708 6.40 10.00 5 137.10 zero 3.93 On February 1, 2024, February 16, 2024, March 22, 2024 and April 2, 2024, the Company made principal payments towards the first tranche in the amounts of $ 625,000 125,000 125,000 750,000 103 643,750 128,750 128,750 772,500 91,965 42,917 42,917 257,500 4.80 2.60 2.00 3.40 441,428 113,300 84,117 881,165 32,247 119,796 17,576 4.80 12.60 574,779 221,449 391,447 20,547 180,566 131,165 On February 5, 2024, the Company entered into the first amendment to the First Tranche Note of the October 2023 SPA; such amendment provides for i) a reduction of the floor price of the conversion price from $ 7.00 3.00 On February 2, 2024 and February 5, 2024, the Company made principal payments towards the second tranche in the amounts of $ 275,000 275,000 103 283,250 283,250 94,417 94,417 3.40 3.60 323,094 339,334 48,094 64,334 As of April 2024, both tranches of the October 2023 SPA were fully repaid, and as of October 31, 2024 and 2023, the balance of the convertible notes, net of discounts, was $ 0 1,217,597 1,063,372 40,547 March 2024 Debt Financing The Company executed a Securities Purchase Agreement, dated March 27, 2024 (the “SPA”) with an institutional investor (the “March 2024 Investor”), which March 2024 Investor signed and funded on April 5, 2024, and pursuant to which the Company raised gross proceeds of $ 184,500 164,500 In connection with the March 2024 Debt Financing, the Company issued an unsecured promissory note to the March 2024 Investor, dated March 27, 2024, in the principal amount of $ 211,500 27,000 13 12 118,440 29,610 29,610 29,610 29,610 3 25,380 The Investor Note contains provisions constituting an Event of Default (as such term is defined in the March 2024 Investor Note) and, upon an Event of Default, the March 2024 Investor Note will be accelerated and become due and payable in an amount equal to 150% of all amounts due and payable under the March 2024 Investor Note with interest at a default rate of 22% per annum. In addition, upon an Event of Default, the March 2024 Investor has the right to convert all or any outstanding amount of the March Investor Note into shares of the Company’s common stock at a conversion price equal to the greater of (i) 75% of the Market Price (as such term is defined in the March 2024 Investor Note) or (ii) the conversion floor price, which is $ 1.42340 On September 30, 2024 and October 30, 2024, the Company made cash payments in the amounts of $ 118,440 29,610 67,514 0 51,064 0 Note Payable – Related Party On March 26, 2024, the Company borrowed $ 125,000 125,000 10 1,000,000 50,000 On September 26, 2024 and October 28, 2024, the Company entered into the first and second amendments, respectively, to the Peterson Note; each amendment extended the maturity dates to October 28, 2024 and November 30, 2024, respectively, and added a $ 5,000 135,000 0 7,586 0 April 2024 Convertible Debt Financings On April 24, 2024, the Company entered into an Amended and Restated Securities Purchase Agreement (the “A&R SPA”), pursuant to which two institutional investors (the “April 2024 Investors”) provided an aggregate of $ 720,000 664,000 75,000 37,500 9.80 8.00 366,000 301,500 Pursuant to the provisions of the A&R SPA, the Company granted “piggy-back registration rights” to the April 2024 Investors for the registration for resale of the Commitment Shares and the Conversion Shares (defined hereafter). Additionally, until 18 months after the later of (i) August 16, 2024 or the full repayment of the April 2024 Investors Notes (defined hereafter), the Company provided the April 2024 Investors with the right to jointly participate in future financings in an amount up to 100 45 In connection with the April 2024 Financings, the Company issued Senior Secured Convertible Promissory Notes to the April 2024 Investors in the aggregate principal amount of $ 800,000 80,000 10 15 1,000,000 50 5,000,000 August 16, 2024 56,000 136,000 The April 2024 Investors Notes are convertible into shares common stock of the Company (the “Conversion Shares”) at a per share conversion price of $ 5.00 The Company also granted to the April 2024 Investors a senior security interest in and to all of the Company’s assets and non-real estate properties, subject to certain exceptions, securing repayment of the April 2024 Investors Notes as set forth in an Amended and Restated Security Agreement, dated April 24, 2024, between the Company and the April 2024 Investors (the “A&R Security Agreement”). On August 6, 2024, in connection with a financing dated on that date, the Company made two cash payments of $ 25,000 On August 14, 2024, the Company entered into an amendment to the April 2024 Debt Financings to extend the maturity dates of the notes from August 16, 2024 to September 16, 2024; the amendment also provided for the accrual of interest on the outstanding principal balance of the notes at a rate of 15 On October 1, 2024, the Company made aggregate principal payments towards the April 2024 Debt Financings in the amount of $ 682,031 7,031 224,291 3.44 3.66 729,405 47,373 On October 18, 2024, the Company made a final principal payment towards the April 2024 Debt Financings in the amount of $ 75,000 25,000 3.00 3.10 77,450 2,450 As of October 31, 2024 and 2023, the balance of the April 2024 Debt Financings was $ 0 816,445 0 June 2024 Convertible Debt Financings On June 27, 2024, the Company entered into a securities purchase agreement (the “June 2024 SPA”) with the same April 2024 Investors (the “June 2024 Investors”). Pursuant to the terms and conditions of the June 2024 SPA, each June 2024 Investor provided financing of $ 360,000 10 720,000 676,200 10 400,000 37,231 7.90500 74,461 257,701 6.00 7.90500 5 132.52 zero 4.29 The June 2024 Notes are initially convertible into shares of Common Stock (the “June 2024 Conversion Shares”) at a conversion price of $ 7.90500 2.40 Commencing on the 90 th 103 The Company may repay all or any portion of the outstanding principal amount of the June 2024 Notes, subject to a 5 On September 26, 2024, October 1, 2024, and October 30, 2024, the Company made principal payments towards the June 2024 Notes in the amounts of $ 88,888 50,000 88,888 103 91,556 51,500 91,556 30,520 17,167 38,150 3.38 3.66 2.58 103,091 62,830 98,422 14,203 12,830 9,534 2,317 3.38 7,838 As of October 31, 2024 and 2023, the balance of the June 2024 Notes was $ 322,419 0 131,696 0 August 1, 2024 Financing On August 1, 2024, the Company entered into a Securities Purchase Agreement (the “August 1 st 134,000 110,625 152,000 18,000 11.8 12 May 30, 2025 85,120 21,280 21,280 21,280 21,280 3 18,240 As of October 31, 2024 and 2023, the balance of the August 1, 2024 Financing was $ 128,588 0 17,963 0 August 6, 2024 Financing On August 6, 2024, the Company entered into a Securities Purchase Agreement (the “August 6 th 225,000 199,250 255,225 30,225 11.8 12 May 30, 2025 142,926 35,731.50 35,731.50 35,731.50 35,731.50 3 30,627 Additionally, in conjunction with two prior investors and the April 2024 Debt Financing, the Company will make two payments of $ 25,000 As of October 31, 2024 and 2023, the balance of the August 6, 2024 Financing was $ 224,327 0 25,077 0

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	12 Months Ended
	Oct. 31, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 11 – STOCKHOLDERS’ EQUITY Common Shares The Company is authorized to issue an aggregate of 25,000,000 24,500,000 0.0001 500,000 0.0001 In December 2022, the Company entered into subscription agreements with two accredited investors for the aggregate issuance of 20,000 400,000 0.0001 20.00 In April 2023, the Company consummated its IPO and sold 100,000 60.00 6,000,000 In April 2023, upon consummation of its IPO, the Company also issued 18,750 25 4,500,000 60.00 On April 20, 2023, the Company issued 625 40.00 25,000 On May 1, 2023, the Company issued 35,000 43.00 1,505,000 753,188 440,219 311,593 On May 2, 2023, June 23, 2023 and July 11, 2023, the Company issued 1,250 5,000 5,000 0.0001 42.00 17.60 24.20 52,500 88,000 121,000 On June 30, 2023, the Company issued 2,400 0.0001 33.40 80,159 On June 30, 2023, the Company issued a Form S-1/A, which registered for resale (i) up to 157,466 shares of common stock, par value $0.0001 per share which the selling stockholders may acquire upon the exercise of outstanding common warrants and (ii) up to 25,000 shares of common stock, which the selling stockholders may acquire upon the exercise of outstanding pre-funded warrants. Such warrants were issued to the selling stockholders in connection with securities purchase agreements entered into on January 28, 2022 and September 20, 2022. The Company recorded 34,993 shares of common stock that are not exercised but registered in accordance with their common warrant agreements and 25,000 shares of common stock that are not exercised but registered in accordance with their pre-funded warrant agreements upon the filing of this Form S-1/A On July 20, 2023, the Company issued 10,000 21.40 213,000 On September 2, 2023, the Company issued 21,250 0.0001 12.80 273,275 177,259 96,016 On October 16, 2023, pursuant to the Peterson Employment Agreement, the Company issued Mr. Peterson is a grant of 50,000 5.40 271,000 The restricted stock grant vests over a period of two years, with 25% of the shares of restricted stock vesting six months after the Peterson Employment Agreement Effective Date, and the remainder vesting in equal tranches on each of the 12-, 18-, and 24-month anniversary dates of the Peterson Employment Agreement 267,659 3,341 On November 11, 2023, the Company entered into an agreement with a vendor to provide marketing and distribution services for a period of six months, with compensation in the form of 10,000 10,000 9.60 95,200 On December 18, 2023, December 29, 2023 and January 12, 2024, the Company issued conversion shares which numbered 18,393 18,393 18,393 6.80 6.20 5.80 125,072 114,036 105,575 36,698 35,837 49,935 36,770 24,873 30,510 On February 1, 2024, February 16, 2024, March 22, 2024 and April 2, 2024, the Company issued conversion shares numbering 91,965 42,917 42,917 257,500 4.80 2.60 2.00 3.40 441,428 113,300 84,117 881,165 32,247 119,796 17,576 4.80 12.60 574,779 221,449 391,447 20,547 180,566 131,165 On February 2, 2024 and February 5, 2024, the Company made principal payments towards the second tranche in the amounts of $ 275,000 275,000 103 283,250 283,250 94,417 94,417 3.40 3.60 323,094 339,334 48,094 64,334 On March 20, 2024, the Company issued 5,000 2.20 10,500 On March 26, 2024, the Company entered into an agreement with consultants to provide marketing services; the agreement has an effective date of April 26, 2024 and a term from April 1, 2024 through June 30, 2024. The terms provide for a one-time cash payment of $ 100,000 50,000 30,000 50,000 7.40 368,000 On April 16, 2024 and April 24, 2024, the Company issued 37,500 37,500 9.80 8.00 366,000 301,500 On April 29, 2024, the Company entered into an agreement with consultants to provide marketing services; the agreement has a term from April 29, 2024 through October 29, 2024. The terms provide for a $ 30,000 30,000 30,000 7.40 220,800 On September 9, 2024, the Company entered into a media advertising agreement with a consultant; the agreement has an initial term of sixty days and provides for a $ 100,000 50,000 50,000 12,500 3.60 43,800 On September 26, 2024, October 1, 2024, and October 30, 2024, the Company made principal payments towards the June 2024 Notes in the amounts of $ 88,888 50,000 88,888 103 91,556 51,500 91,556 30,520 17,167 38,150 3.38 3.66 2.58 103,091 62,830 98,422 2,317 3.38 7,838 On October 1, 2024, the Company made aggregate principal payments towards the April 2024 Debt Financings in the amount of $ 682,031 7,031 224,291 3.44 3.66 729,405 47,373 On October 18, 2024, the Company made a final principal payment towards the April 2024 Debt Financings in the amount of $ 75,000 25,000 3.00 3.10 77,450 2,450 Warrants Other Warrants In December 2022, the Company entered into subscription agreements with two accredited investors for the aggregate issuance of 20,000 In April 2023, the Company also issued warrants to purchase 5,000 66.00 October 2023 SPA with Warrants On October 4, 2023 and December 29, 2023, the Company entered into placement agent agreements with Spartan (see Note 8 for further information) for their role in connection with the two tranche fundings related to the October 2023 SPA; among other things, the agreements provide the agent with equity-classified warrants to purchase a number of common shares equal to 5% of the number of common shares initially issuable upon conversion of each note tranche. For the first tranche, the Company issued to Spartan warrants to purchase 4,167 38,029 11.00 26.40 5 137.10 zero 4.72 2,750 14,753 6.40 11.00 5 137.10 zero 3.93 On January 2, 2024, the second tranche of the October 2023 SPA was funded (see Note 9 for further information); in connection with this funding, the Company issued to the investor equity warrants to purchase up to 22,279 98,708 6.40 10.00 5 137.10 zero 3.93 June 2024 SPA with Warrants On June 27, 2024, the Company entered into the June 2024 SPA with the June 2024 Investors (see Note 9 above); pursuant to the terms and conditions of the agreement, in consideration for providing financing, the Company issued to each June 2024 Investor a warrant to purchase 37,231 7.90500 74,461 257,701 6.00 7.90500 5 132.52 zero 4.29 A summary of the warrant activity during the years ended October 31, 2024 and 2023 is presented below: SCHEDULE OF WARRANT ACTIVITY Weighted Weighted Average Average Remaining Number of Exercise Life in Intrinsic Warrants Price Years Value Outstanding, November 1, 2022 - $ - - $ - Issued 238,803 20.77 3.1 - Exercised (145,065 ) 20.51 - Cancelled - - Expired (5,402 ) - Outstanding, November 1, 2023 88,336 22.35 3.9 211,200 Issued 103,658 9.18 4.5 - Exercised - - - - Cancelled - - - - Expired - - - - Outstanding, October 31, 2024 191,994 $ 15.24 3.8 $ 47,160 Exercisable, October 31, 2024 191,994 $ 15.24 3.8 $ 47,160 A summary of outstanding and exercisable warrants as of October 31, 2024 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS Warrants Outstanding Warrants Exercisable Weighted Average Exercise Number of Remaining Number of Price Shares Life in Years Shares $ 0.20 20,000 3.5 20,000 $ 30.00 20,000 0.1 20,000 $ 66.00 5,000 3.5 5,000 $ 24.00 43,336 3.9 43,336 $ 26.40 4,167 3.9 4,167 $ 10.00 22,279 4.2 22,279 $ 11.00 2,750 4.2 2,750 $ 7.91 74,462 4.7 74,462 191,994 3.8 191,994 Stock Options A summary of the option activity during the years ended October 31, 2024 and 2023 is presented below: SCHEDULE OF STOCK OPTION ACTIVITY Weighted Weighted Average Average Remaining Number of Exercise Life in Intrinsic Options Price Years Value Outstanding, November 1, 2022 - $ - - $ - Issued 6,000 10.46 4.8 1,800 Outstanding, November 1, 2023 6,000 10.46 4.8 1,800 Issued - - - - Exercised - - - - Cancelled - - - - Expired - - - - Outstanding, October 31, 2024 6,000 $ 10.46 3.8 $ - Exercisable, October 31, 2024 6,000 $ 10.46 3.8 $ - A summary of outstanding and exercisable options as of October 31, 2024 and 2023 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS Options Outstanding Options Exercisable Weighted Average Exercise Number of Remaining Number of Price Shares Life in Years Shares $ 10.46 6,000 3.8 6,000 6,000 3.8 6,000 On August 15, 2023, the Company issued five-year options to purchase 6,000 10.46 24 55,711 The assumptions used in the Black-Scholes valuation method for these options issued in 2023 were as follows: SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES VALUATION METHOD FOR OPTIONS Risk free interest rate 4.36 % Expected term (years) 5.0 Expected volatility 137.1 % Expected dividends 0 %

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Oct. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12 – SUBSEQUENT EVENTS In accordance with ASC 855 – Subsequent Events, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before financial statements are issued, the Company has evaluated all events and transactions that occurred after October 31, 2024, through the date the financial statements were issued. Except for the following, there are no subsequent events identified that would require disclosure in the financial statements. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard from the NYSE American On November 5, 2024, the Company received notice from NYSE American that NYSE American had halted trading in the shares of the Common Stock until the effectiveness of the reverse stock split the Company intended to effect because its common stock was consistently selling at a low selling price per share in violation of Section 1003(f)(v) of the NYSE American Company Guide. NYSE American informed the Company that it would attempt to reopen trading in the Common Stock on November 15, 2024, which is when the common stock is expected to begin trading on a post-split basis, provided that NYSE American no longer deems the selling price of the Common Stock to be too low. Reverse Stock Split On November 14, 2024, the Company filed a Certificate of Amendment to its Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a Reverse Stock Split; once effective, every twenty (20) shares of the Company’s issued and outstanding common stock will automatically be converted into one share of common stock, without any change in the par value per share. In addition, (i) a proportionate adjustment will be made to the per share exercise price and the number of shares issuable upon the exercise of all outstanding stock options and warrants to purchase shares of common stock, to the extent that the exercise price of such warrants is not based solely on the market price of the common stock at the time of exercise, (ii) a proportionate adjustment will be made to any fixed conversion prices for other convertible securities of the Company, including any conversion floor prices and (iii) the number of shares reserved for issuance pursuant to the Company’s equity incentive plans will also be reduced proportionately. Any fraction of a share of common stock that would be created as a result of the Reverse Stock Split will be rounded up to the nearest whole share. The Reverse Stock Split became effective as of 4:30 p.m., Eastern Time, on November 14, 2024, and the Company’s common stock began trading on a split-adjusted basis when the market opened on November 15, 2024. Letter of Intent for Working Interest in NovaCor Exploration Ltd. On December 19, 2024, the Company issued a press release announcing that it entered into a non-binding letter of intent relating to the acquisition of a 100% working interest in certain petroleum and natural gas assets held by NovaCor Exploration Ltd., which are located in the Lloydminster, Saskatchewan heavy oil region in Canada. Independent Contractor Agreement with Greg Overholtzer On December 31, 2024, the employment agreement between the Company and Mr. Overholtzer ended and on January 1, 2025, the Company entered into an independent contractor agreement with Mr. Overholtzer, under which he continues to serve as the Chief Financial Officer of the Company and is paid a monthly fee of $ 12,500 Consulting Agreement with Redwood Empire Financial Communications, LLC On January 1, 2025, the Company entered into a consulting agreement with Redwood Empire Financial Communications, LLC for investor communications services; the agreement includes monthly compensation of $ 7,500 20,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”).
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transaction and disclosure of contingent assets and liabilities at the date of the financial statements, and the revenue and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Some of the more significant estimates required to be made by management include estimates of oil and natural gas reserves (when and if assigned) and related present value estimates of future net cash flows therefrom, the carrying value of oil and natural gas properties, ARO and the valuation of equity-based transactions. Accordingly, actual results could differ significantly from those estimates.
Cash and cash equivalents	Cash and cash equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no
Prepaid Expenses	Prepaid Expenses Prepaid expenses consist primarily of prepaid services which will be expensed as the services are provided within twelve months. As of October 31, 2024 and 2023, the balances of the prepaids account were $ 279,274 133,417
Debt Issuance Costs	Debt Issuance Costs Costs incurred in connection with the issuance of the Company’s debt have been recorded as a direct reduction against the debt and amortized over the life of the associated debt as a component of interest expense. As of October 31, 2024 and 2023, the Company recorded $ 259,903 350,320
Oil and Gas Assets and Exploration Costs – Successful Efforts	Oil and Gas Assets and Exploration Costs – Successful Efforts The Company’s projects are in exploration and/or early production stages and the Company began generating revenue from its operations during the quarterly period ended April 30, 2024. It applies the successful efforts method of accounting for crude oil and natural gas properties. Under this method, exploration costs such as exploratory, geological, and geophysical costs, delay rentals and exploratory overhead are expensed as incurred. If an exploratory property provides evidence to justify potential development of reserves, drilling costs associated with the property are initially capitalized, or suspended, pending a determination as to whether a commercially sufficient quantity of proved reserves can be attributed to the area as a result of drilling. At the end of each quarter, management reviews the status of all suspended exploratory property costs considering ongoing exploration activities; in particular, whether the Company is making sufficient progress in its ongoing exploration and appraisal efforts. If management determines that future appraisal drilling or development activities are unlikely to occur, associated exploratory well costs are expensed. Costs to acquire mineral interests in crude oil and/or natural gas properties, drill and equip exploratory wells that find proved reserves and drill and equip development wells are capitalized. Acquisition costs of unproved leaseholds are assessed for impairment during the holding period and transferred to proven crude oil and/or natural gas properties to the extent associated with successful exploration activities. Significant undeveloped leases are assessed individually for impairment, based on the Company’s current exploration plans, and a valuation allowance is provided if impairment is indicated. Capitalized costs from successful exploration and development activities associated with producing crude oil and/or natural gas leases, along with capitalized costs for support equipment and facilities, are amortized to expense using the unit-of-production method based on proved crude oil and/or natural gas reserves on a field-by-field basis, as estimated by qualified petroleum engineers. The Company currently has four wells that are producing (one well in President’s Field in the South Salinas Project and three wells at the McCool Ranch Oil Field) and is evaluating the impact of production on the reserve determination for those wells and fields. The Company expects to add the reserve value of such fields to the Company’s reserve report after a further period of observation and review of the oil production. As of October 31, 2024 and 2023, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization.
Unproved oil and natural gas properties	Unproved oil and natural gas properties Unproved oil and natural gas properties have unproved lease acquisition costs, which are capitalized until the lease expires or otherwise until the Company specifically identifies a lease that will revert to the lessor, at which time the Company charges the associated unproved lease acquisition costs to exploration costs. Unproved oil and natural gas properties are not subject to amortization and are assessed periodically for impairment on a property-by-property basis based on remaining lease terms, drilling results or future plans to develop acreage. The Company currently has four wells that are producing (one well in President’s Field in the South Salinas Project and three wells at the McCool Ranch Oil Field) and is evaluating the impact of production on the reserve determination for those wells and fields. The Company expects to add the reserve value of such fields to the Company’s reserve report after a further period of observation and review of the oil production. As of October 31, 2024 and 2023, all of the Company’s oil and gas properties were classified as unproved properties and were not subject to depreciation, depletion and amortization; see further discussion in Note 6.
Impairment of Other Long-lived Assets	Impairment of Other Long-lived Assets The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical cost-carrying value of an asset may no longer be appropriate. The Company assesses the recoverability of the carrying value of the asset by estimating the future net undiscounted cash flows expected to result from the asset, including eventual disposition. If the future net undiscounted cash flows are less than the carrying value of the asset, an impairment loss is recorded equal to the difference between the asset’s carrying value and estimated fair value. With regards to oil and gas properties, this assessment applies to proved properties . As of October 31, 2024 and 2023, the Company had no
Asset Retirement Obligations	Asset Retirement Obligations ARO consists of future plugging and abandonment expenses on oil and natural gas properties. In connection with the South Salinas Project (“SSP”) acquisition described above, the Company acquired the plugging and abandonment liabilities associated with six non-producing wells. The fair value of the ARO was recorded as a liability in the period in which the wells were acquired with a corresponding increase in the carrying amount of oil and natural gas properties not subject to impairment. The Company plans to utilize the six wellbores acquired in the SSP acquisition in future exploration, production and/or disposal (i.e., disposal of produced water or CO2 by injection) activities. The liability is accreted for the change in its present value each period based on the expected dates that the wellbores will be required to be plugged and abandoned. The capitalized cost of ARO is included in oil and gas properties and is a component of oil and gas property costs for purposes of impairment and, if proved reserves are found, such capitalized costs will be depreciated using the units-of-production method. The asset and liability are adjusted for changes resulting from revisions to the timing or the amount of the original estimate when deemed necessary. If the liability is settled for an amount other than the recorded amount, a gain or loss is recognized. Components of the changes in ARO for the years ended October 31, 2023 and 2024 are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO ARO, ending balance – October 31, 2022 $ 48,313 Accretion expense 2,778 ARO, ending balance – October 31, 2023 51,091 Accretion expense 2,778 ARO, ending balance – October 31, 2024 53,869 Less: ARO – current 2,778 ARO, net of current portion – October 31, 2024 $ 51,091
Related Parties	Related Parties Related parties are directly or indirectly related to the Company, through one or more intermediaries and are in control, controlled by, or under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. On September 14, 2021, the Company acquired an 82.75 85.775 245,000 45 1 1
Income Taxes	Income Taxes Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets, including tax loss and credit carry forwards, and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company utilizes ASC 740, Income Taxes For uncertain tax positions that meet a “more likely than not” threshold, the Company recognizes the benefit of uncertain tax positions in the financial statements. The Company’s practice is to recognize interest and penalties, if any, related to uncertain tax positions in income tax expense in the statements of operations when a determination is made that such expense is likely. The Company is subject to income tax examinations by major taxing authorities since inception.
Fair Value Measurements	Fair Value Measurements The carrying values of financial instruments comprising cash and cash equivalents, payables, and notes payable-related party approximate fair values due to the short-term maturities of these instruments. The notes payable- related party is considered a level 3 measurement. As defined in ASC 820, Fair Value Measurements and Disclosures Level 1: Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Level Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. Level Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The significant unobservable inputs used in the fair value measurement for nonrecurring fair value measurements of long-lived assets include pricing models, discounted cash flow methodologies and similar techniques. There are no assets or liabilities measured at fair value on a recurring basis. Assets and liabilities accounted for at fair value on a non-recurring basis in accordance with the fair value hierarchy include the initial allocation of the asset acquisition purchase price, including asset retirement obligations, the fair value of oil and natural gas properties and the assessment of impairment. The fair value measurements and allocation of assets acquired are measured on a nonrecurring basis on the acquisition date using an income valuation technique based on inputs that are not observable in the market and therefore represent Level 3 inputs. Significant inputs used to determine the fair value include estimates of: (i) reserves; (ii) future commodity prices; (iii) operating and development costs; and (iv) a market-based weighted average cost of capital rate. The underlying commodity prices embedded in the Company’s estimated cash flows are the product of a process that begins with NYMEX forward curve pricing, adjusted for estimated location and quality differentials, as well as other factors that the Company’s management believes will impact realizable prices. These inputs require significant judgments and estimates by the Company’s management at the time of the valuation. The fair value of additions to the asset retirement obligation liabilities is measured using valuation techniques consistent with the income approach, which converts future cash flows to a single discounted amount. Significant inputs to the valuation include: (i) estimated plug and abandonment cost per well for all oil and natural gas wells and for all disposal wells; (ii) estimated remaining life per well; (iii) future inflation factors; and (iv) the Company’s average credit-adjusted risk-free rate. These assumptions represent Level 3 inputs. If the carrying amount of its proved oil and natural gas properties, which are assessed for impairment under ASC 360 – Property, Plant and Equipment,
Net Loss Per Share	Net Loss Per Share Basic and diluted net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is computed similar to basic loss per share, except the weighted average number of common shares outstanding are increased to include additional shares from the assumed exercise of share options, warrants and convertible notes, if dilutive. The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been anti-dilutive: SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI_DILUTIVE As of October 31, As of October 31, 2024 2023 Warrants 19,176 (1) 19,812 (2) Total potentially dilutive securities 19,176 19,812 (1) Balance consists of potentially dilutive shares based on 191,994 88,336 (2) Balance consists of restricted stock units granted to five outside directors and restricted shares issued to executives.
Environmental Expenditures	Environmental Expenditures The operations of the Company have been, and may in the future be, affected from time to time to varying degrees by changes in environmental regulations, including those for future reclamation and site restoration costs. Both the likelihood of new regulations and their overall effect upon the Company vary greatly and are not predictable. The Company’s policy is to meet or, if possible, surpass standards set by relevant legislation by application of technically proven and economically feasible measures. Environmental expenditures that relate to ongoing environmental and reclamation programs are charged against earnings as incurred or capitalized and amortized depending on their future economic benefits. All of these types of expenditures incurred since inception have been charged against earnings due to the uncertainty of their future recoverability. Estimated future reclamation and site restoration costs, when the ultimate liability is reasonably determinable, are charged against earnings over the estimated remaining life of the related business operation, net of expected recoveries.
Recent Accounting Pronouncements	Recent Accounting Pronouncements All recently issued but not yet effective accounting pronouncements have been deemed to be not applicable or immaterial to the Company.
Reclassification of Expenses	Reclassification of Expenses Certain amounts in the prior periods presented have been reclassified to the current period financial statement presentation. This reclassification has no effect on previously reported net income.
Subsequent Events	Subsequent Events The Company evaluated all events and transactions that occurred after October 31, 2024 through the date of the filing of this report. See Note 12 for such events and transactions.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Oct. 31, 2024
Accounting Policies [Abstract]
SCHEDULE OF COMPONENTS OF CHANGES IN ARO	Components of the changes in ARO for the years ended October 31, 2023 and 2024 are shown below: SCHEDULE OF COMPONENTS OF CHANGES IN ARO ARO, ending balance – October 31, 2022 $ 48,313 Accretion expense 2,778 ARO, ending balance – October 31, 2023 51,091 Accretion expense 2,778 ARO, ending balance – October 31, 2024 53,869 Less: ARO – current 2,778 ARO, net of current portion – October 31, 2024 $ 51,091
SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI_DILUTIVE	The following common share equivalents are excluded from the calculation of weighted average common shares outstanding, because their inclusion would have been anti-dilutive: SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI_DILUTIVE As of October 31, As of October 31, 2024 2023 Warrants 19,176 (1) 19,812 (2) Total potentially dilutive securities 19,176 19,812 (1) Balance consists of potentially dilutive shares based on 191,994 88,336 (2) Balance consists of restricted stock units granted to five outside directors and restricted shares issued to executives.

REVENUE FROM CONTRACTS WITH C_2

REVENUE FROM CONTRACTS WITH CUSTOMERS (Tables)	12 Months Ended
	Oct. 31, 2024
Revenue from Contract with Customer [Abstract]
SCHEDULE OF DISAGGREGATES REVENUE	The following table disaggregates revenue by significant product type for the periods below: SCHEDULE OF DISAGGREGATES REVENUE As of October 31, As of October 31, 2024 2023 Oil sales $ 213,204 $ - Total revenues from customers $ 213,204 $ -

OIL AND NATURAL GAS PROPERTIES

OIL AND NATURAL GAS PROPERTIES (Tables)	12 Months Ended
	Oct. 31, 2024
Property, Plant and Equipment [Abstract]
SCHEDULE OF OIL AND NATURAL GAS PROPERTIES	The following tables summarize the Company’s oil and gas activities. SCHEDULE OF OIL AND NATURAL GAS PROPERTIES As of October 31, As of October 31, 2024 2023 Oil and gas properties – not subject to amortization $ 11,119,119 $ 9,947,742 Accumulated impairment — — Oil and gas properties – not subject to amortization, net $ 11,119,119 $ 9,947,742

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Oct. 31, 2024
Income Tax Disclosure [Abstract]
SCHEDULE OF DEFERRED TAX ASSETS	Significant components of the Company’s deferred tax assets are summarized below. SCHEDULE OF DEFERRED TAX ASSETS As of October 31, As of October 31, 2024 2023 Deferred tax assets: Net operating loss carry forwards $ 1,699,000 $ 1,095,000 Total deferred tax asset 1,699,000 1,095,000 Valuation allowance (1,699,000 ) (1,095,000 ) Deferred tax asset, net $ - $ -
SCHEDULE OF EFFECTIVE FEDERAL INCOME TAX RATE RECONCILIATION	A reconciliation of the statutory federal income tax benefit to actual tax benefit is as follows: SCHEDULE OF EFFECTIVE FEDERAL INCOME TAX RATE RECONCILIATION As of October 31, As of October 31, 2024 2023 Federal statutory blended income tax rates (21 )% (21 )% State statutory income tax rate, net of federal benefit - % - % Change in valuation allowance 21 % 21 % Effective tax rate - % - %

NOTES PAYABLE (Tables)

NOTES PAYABLE (Tables)	12 Months Ended
	Oct. 31, 2024
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	Notes payable as of October 31, 2024 and 2023 consisted of the following: SCHEDULE OF NOTES PAYABLE As of As of October 31, 2024 October 31, 2023 Convertible note, net of discounts $ - $ 1,217,597 Promissory notes, net of discounts 742,852 - Note payable – related party 135,000 - Total Notes payable $ 877,852 $ 1,217,597

STOCKHOLDERS_ EQUITY (Tables)

STOCKHOLDERS’ EQUITY (Tables)	12 Months Ended
	Oct. 31, 2024
Equity [Abstract]
SCHEDULE OF WARRANT ACTIVITY	A summary of the warrant activity during the years ended October 31, 2024 and 2023 is presented below: SCHEDULE OF WARRANT ACTIVITY Weighted Weighted Average Average Remaining Number of Exercise Life in Intrinsic Warrants Price Years Value Outstanding, November 1, 2022 - $ - - $ - Issued 238,803 20.77 3.1 - Exercised (145,065 ) 20.51 - Cancelled - - Expired (5,402 ) - Outstanding, November 1, 2023 88,336 22.35 3.9 211,200 Issued 103,658 9.18 4.5 - Exercised - - - - Cancelled - - - - Expired - - - - Outstanding, October 31, 2024 191,994 $ 15.24 3.8 $ 47,160 Exercisable, October 31, 2024 191,994 $ 15.24 3.8 $ 47,160
SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS	A summary of outstanding and exercisable warrants as of October 31, 2024 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS Warrants Outstanding Warrants Exercisable Weighted Average Exercise Number of Remaining Number of Price Shares Life in Years Shares $ 0.20 20,000 3.5 20,000 $ 30.00 20,000 0.1 20,000 $ 66.00 5,000 3.5 5,000 $ 24.00 43,336 3.9 43,336 $ 26.40 4,167 3.9 4,167 $ 10.00 22,279 4.2 22,279 $ 11.00 2,750 4.2 2,750 $ 7.91 74,462 4.7 74,462 191,994 3.8 191,994
SCHEDULE OF STOCK OPTION ACTIVITY	A summary of the option activity during the years ended October 31, 2024 and 2023 is presented below: SCHEDULE OF STOCK OPTION ACTIVITY Weighted Weighted Average Average Remaining Number of Exercise Life in Intrinsic Options Price Years Value Outstanding, November 1, 2022 - $ - - $ - Issued 6,000 10.46 4.8 1,800 Outstanding, November 1, 2023 6,000 10.46 4.8 1,800 Issued - - - - Exercised - - - - Cancelled - - - - Expired - - - - Outstanding, October 31, 2024 6,000 $ 10.46 3.8 $ - Exercisable, October 31, 2024 6,000 $ 10.46 3.8 $ -
SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS	A summary of outstanding and exercisable options as of October 31, 2024 and 2023 is presented below: SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS Options Outstanding Options Exercisable Weighted Average Exercise Number of Remaining Number of Price Shares Life in Years Shares $ 10.46 6,000 3.8 6,000 6,000 3.8 6,000
SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES VALUATION METHOD FOR OPTIONS	The assumptions used in the Black-Scholes valuation method for these options issued in 2023 were as follows: SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES VALUATION METHOD FOR OPTIONS Risk free interest rate 4.36 % Expected term (years) 5.0 Expected volatility 137.1 % Expected dividends 0 %

NATURE OF THE ORGANIZATION AN_2

NATURE OF THE ORGANIZATION AND BUSINESS (Details Narrative)

1 Months Ended

Nov. 10, 2023 USD ($) a

Apr. 20, 2023 USD ($) shares

Sep. 30, 2021 USD ($) $ / shares shares

Sep. 14, 2021 shares

Jan. 31, 2024 USD ($)

Dec. 31, 2023 USD ($)

Nov. 30, 2023 USD ($) a

Apr. 30, 2023 shares

Oct. 31, 2024 a $ / shares

Feb. 26, 2024 $ / shares

Oct. 31, 2023 a $ / shares

Oct. 16, 2023

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Common stock price per share | $ / shares

$ 0.0001

$ 0.0001

$ 0.0001

IPO [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Number of shares issued | shares

18,750

Number of shares sold | shares

100,000

100,000

Gross proceeds from sale of shares

$ 6,000,000

ARLO Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Area of land | a

960

Payments to acquire loans and lease

$ 2,000,000

Business combination agreement and funded amount

$ 25,000

$ 200,000

Finance lease interest percentage

2.25%

2%

Trio LLC [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Working interest

21.91832%

Trio LLC [Member] | McCool Ranch Purchase Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Working interest

21.91832%

21.91832%

Heavy Sweet Oil [Member] | ARLO Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Area of land | a

960

Business acquisition description

November 2023, the Company entered into a leasehold acquisition and development option agreement (“ARLO Agreement”) with Heavy Sweet Oil, LLC (“HSO”), which gave the Company a 9-month option for the exclusive right to acquire up to a 20% interest in a 960-acre drilling and production program in the Asphalt Ridge leases for $2,000,000.

Percentage of production share

17.75%

20%

Payments to acquire loans and lease

$ 1,775,000

$ 2,000,000

Trio LLC [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Number of shares issued | shares

245,000,000,000

Business acquisition percentage

45%

45%

1%

1%

Trio LLC [Member] | Purchase and Sale Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Area of land | a

9,300

9,300

Payments to acquire businesses net of cash acquired

$ 300,000

Non interest bearing notes payable

$ 3,700,000

Number of shares issued | shares

245,000

Common stock price per share | $ / shares

$ 0.0001

Royalties percentage

68.62%

Working interest percentage

3.80%

Trio LLC [Member] | South Salinas Project [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Business acquisition increase in percentage of working interest

82.75%

Working interest

82.75%

85.775%

Area of land | a

9,300

SCHEDULE OF COMPONENTS OF CHANG

SCHEDULE OF COMPONENTS OF CHANGES IN ARO (Details) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
ARO, ending balance	$ 51,091	$ 48,313
Accretion expense	2,778	2,778
ARO, ending balance	53,869	51,091
Less: ARO - current	2,778
ARO, net of current portion	$ 51,091	$ 48,313

SCHEDULE OF WEIGHTED AVERAGE CO

SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI_DILUTIVE (Details) - shares	12 Months Ended
	Oct. 31, 2024		Oct. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	19,176		19,812
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Warrants	19,176	[1]	19,812	[2]
[1]Balance consists of potentially dilutive shares based on 191,994 88,336

SCHEDULE OF WEIGHTED AVERAGE _2

SCHEDULE OF WEIGHTED AVERAGE COMMON SHARES OUTSTANDING ANTI-DILUTIVE (Details) (Parenthetical) - shares	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Accounting Policies [Abstract]
Dilutive shares outstanding	191,994	88,336

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) shares in Millions	Sep. 14, 2021	Oct. 31, 2024	Oct. 31, 2023	Apr. 30, 2023	Sep. 30, 2021
Cash equivalents		$ 0	$ 0
Prepaid expense, current		279,274	133,417
Debt issuance costs, gross		259,903	350,320
Impairment of long-lived assets		$ 0	$ 0
Trio LLC [Member]
Issuance of share	245,000
Business acquisition percentage	45%	1%	1%		45%
Trio LLC [Member] | South Salinas Project [Member]
Business acquisition percentage.	82.75%			85.775%

GOING CONCERN AND MANAGEMENT__2

GOING CONCERN AND MANAGEMENT’S LIQUIDITY PLANS (Details Narrative) - USD ($)	1 Months Ended					3 Months Ended	12 Months Ended
	Aug. 31, 2024	Apr. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Oct. 31, 2023	Jul. 31, 2024	Oct. 31, 2024	Oct. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Cash					$ 1,561,924		$ 285,945	$ 1,561,924
Working capital							2,025,480
Proceeds from convertible debt							550,000	2,000,000
Accumulated deficit					10,446,882		$ 20,073,679	$ 10,446,882
August Two Thousand Twenty Four [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Debt instrument, issued, principal	$ 359,000
At The Market Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from convertible debt	$ 1,174,000
Chief Executive Officer [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from secured debt			$ 125,000
Investor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from secured debt			$ 184,500
Convertible Notes Payable [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from convertible debt				$ 2,371,500	$ 2,371,500
Convertible Notes Payable [Member] | Investor [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from convertible debt		$ 720,000				$ 720,000

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details Narrative) - USD ($)		1 Months Ended	12 Months Ended
	Apr. 20, 2023	Apr. 30, 2023	Oct. 31, 2024	Oct. 31, 2023
Subsidiary, Sale of Stock [Line Items]
Proceeds from public offering	$ 4,940,000			$ 6,000,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Number of sale of stock	100,000	100,000
Sale of stock price per share	$ 60	$ 60
Proceeds from sale of stock	$ 6,000,000
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase shares	5,000	5,000
Warrants exercise price	$ 66	$ 66
Public offering price, percentage	110%

SCHEDULE OF DISAGGREGATES REVEN

SCHEDULE OF DISAGGREGATES REVENUE (Details) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenues from customers	$ 213,204
Oil Sales [Member]
Disaggregation of Revenue [Line Items]
Total revenues from customers	$ 213,204

REVENUE FROM CONTRACTS WITH C_3

REVENUE FROM CONTRACTS WITH CUSTOMERS (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Disaggregation of Revenue [Line Items]
Contract liabilities	$ 0	$ 0
Oil and Natural Gas Revenue [Member] | One Purchaser [Member] | Customer Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Concentration of credit risk percentage	10%	0%

SCHEDULE OF OIL AND NATURAL GAS

SCHEDULE OF OIL AND NATURAL GAS PROPERTIES (Details) - USD ($)	Oct. 31, 2024	Oct. 31, 2023
Property, Plant and Equipment [Abstract]
Oil and gas properties – not subject to amortization	$ 11,119,119	$ 9,947,742
Accumulated impairment
Oil and gas properties – not subject to amortization, net	$ 11,119,119	$ 9,947,742

OIL AND NATURAL GAS PROPERTIE_2

OIL AND NATURAL GAS PROPERTIES (Details Narrative)

1 Months Ended

12 Months Ended

Oct. 31, 2024 USD ($) a

Dec. 29, 2023 USD ($)

Nov. 10, 2023 USD ($) a

Oct. 16, 2023 USD ($)

Sep. 30, 2024 USD ($) a

Jan. 31, 2024 USD ($)

Oct. 31, 2023 USD ($)

Mar. 31, 2023 USD ($) a

Oct. 31, 2024 USD ($) a

Oct. 31, 2023 USD ($)

Feb. 28, 2023 a

May 27, 2022 USD ($) a

Property, Plant and Equipment [Line Items]

Exploration costs

$ 177,416

$ 251,743

Capitalized costs

1,200,000

4,100,000

Long-term purchase commitment, amount

$ 200,000

Long-term purchase commitment, description

the effective date for exclusive rights to the option to purchase 80% of the 100% Before Project Payout Working Interest

Purchase option paid amount

$ 25,000

McCool Ranch Purchase Agreement [Member]

Property, Plant and Equipment [Line Items]

Payment of execution

$ 100,000

$ 100,000

Obligation to pay

400,000

400,000

400,000

Payment for restarting production operation

$ 284,000

284,000

Obligation for remainder of the period

116,000

$ 116,000

Option Pay Two Initial Payment [Member]

Property, Plant and Equipment [Line Items]

Long-term purchase commitment, amount

12,500

Final Subsequent Payment [Member]

Property, Plant and Equipment [Line Items]

Long-term purchase commitment, amount

$ 175,000

Default final payment of option

$ 175,000

ARLO Agreement [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

960

Percentage of interest of leases

20%

Payments to acquire loans and lease

$ 2,000,000

ARLO Agreement [Member] | Minimum [Member]

Property, Plant and Equipment [Line Items]

Payments to acquire loans and lease

$ 500,000

Amended AR Agreement [Member]

Property, Plant and Equipment [Line Items]

Amount agreed to fund

$ 200,000

Amended ARLO Agreement [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

960

Percentage of interest of leases

2%

17.75%

Total purchase price of lease

$ 500,000

Lease payments

$ 225,000

Percentage of interest to acquire infrastructure

2.25%

2.25%

Stock Issued During Period, Value, Stock Options Exercised

$ 1,775,000

Working interest percentage

17.75%

Proceeds from Stock Options Exercised

$ 1,775,000

Trio LLC [Member]

Property, Plant and Equipment [Line Items]

Working interest

21.91832%

21.91832%

Trio LLC [Member] | McCool Ranch Purchase Agreement [Member]

Property, Plant and Equipment [Line Items]

Working interest

21.91832%

21.91832%

21.91832%

First Lease [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

8,417

Non refundable payment

$ 252,512

Second Lease [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

160

160

Delay rental payments

$ 30

$ 30

Group One [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

360

Lease term

20 years

Payments for rent

$ 25

Group Two [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

307.75

Lease term

20 years

Payments for rent

$ 30

Parcel 1 [Member] | McCool Ranch Oil Field [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

480

480

Parcel 2 [Member] | McCool Ranch Oil Field [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

320

320

Parcel 1 and 2 [Member] | McCool Ranch Oil Field [Member]

Property, Plant and Equipment [Line Items]

Area of land | a

800

800

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)															1 Months Ended					12 Months Ended
	Oct. 31, 2024	Oct. 28, 2024	Oct. 21, 2024	Sep. 26, 2024	Sep. 09, 2024	Jul. 11, 2024	Jun. 19, 2024	Mar. 26, 2024	Oct. 23, 2023	Oct. 16, 2023	Sep. 02, 2023	Jul. 20, 2023	May 01, 2023	Apr. 20, 2023	Oct. 31, 2023	May 31, 2023	Dec. 31, 2022	Oct. 31, 2022	Feb. 28, 2022	Oct. 31, 2024	Oct. 31, 2023	Jul. 31, 2024	Feb. 26, 2024	Jul. 11, 2023	Jun. 23, 2023	May 02, 2023
Related Party Transaction [Line Items]
Working interest percentage																				85.775%
Due to operators	$ 103,146														$ 21,651					$ 103,146	$ 21,651
Payable to related party	$ 877,852														$ 1,217,597					$ 877,852	$ 1,217,597
Common stock, par value, per share	$ 0.0001														$ 0.0001					$ 0.0001	$ 0.0001		$ 0.0001
Aggregate fair value																					$ 372,000
Fair value, per share					$ 3.60					$ 5.40
Grant date value
Stock based compensation																				$ 1,534,667	1,044,261
Unsecured debt								$ 125,000
Gross proceeds																				250,666
2022 Equity Incentive Plan [Member]
Related Party Transaction [Line Items]
Stock based compensation																				753,188	440,219
Unrecognized expense	$ 311,593																			311,593
Michael L Peterson [Member]
Related Party Transaction [Line Items]
Annual based salary									$ 350,000
Discretionary bonus percentage									100%
Short term debt								125,000
Unsecured debt								$ 125,000
Interest rate								10%
Gross proceeds								$ 1,000,000
Extension fee		$ 5,000		$ 5,000
Principal balance	$ 135,000														$ 0					135,000	0
Mr Peterson [Member]
Related Party Transaction [Line Items]
Stock based compensation																				267,659	3,341
Monthly cash fee						$ 10,000
Consulting [Member]
Related Party Transaction [Line Items]
Stock based compensation																				$ 97,967	0
Mr. Robin Ross [Member]
Related Party Transaction [Line Items]
Annual based salary						$ 300,000
Discretionary bonus percentage						100%
Restricted Stock Units (RSUs) [Member]
Related Party Transaction [Line Items]
Issuance of common stock for cash, net, shares													35,000
Shares issued, price per share													$ 43
Aggregate fair value													$ 1,505,000
Stock award						50,000	22,500
Shares issued							22,750
Fair value, per share	$ 3.32																			$ 3.32
Grant date value																				$ 166,000
Restricted Stock Units (RSUs) [Member] | 2022 Equity Incentive Plan [Member]
Related Party Transaction [Line Items]
Restricted shares, vesting rate																			25%
Restricted Stock Units (RSUs) [Member] | Director [Member]
Related Party Transaction [Line Items]
Stock award			12,500				50,000
Shares issued	27,500
Fair value, per share	$ 3.32		$ 3.13				$ 6													$ 3.32
Grant date value	$ 91,300		$ 39,125				$ 134,550
Restricted shares, vesting rate			100%				25%
Stock based compensation																				$ 30,651	0
Unrecognized expense	195,199																			195,199
Restricted Stock Units (RSUs) [Member] | Current Director [Member]
Related Party Transaction [Line Items]
Stock award			37,500
Fair value, per share			$ 3.13
Grant date value			$ 117,375
Restricted shares, vesting rate			100%
Stock based compensation																				14,908	0
Unrecognized expense	$ 141,592																			$ 141,592
Restricted Stock Units (RSUs) [Member] | Mr Frank Ingriselli [Member]
Related Party Transaction [Line Items]
Issuance of common stock for cash, net, shares												10,000
Shares issued, price per share												$ 21.40
Aggregate fair value												$ 213,000
Restricted Stock Units (RSUs) [Member] | Mr Frank Ingriselli [Member] | 2022 Equity Incentive Plan [Member]
Related Party Transaction [Line Items]
Grant of restricted shares																			50,000
Restricted Stock Units (RSUs) [Member] | Mr Greg Overholtzer [Member] | 2022 Equity Incentive Plan [Member]
Related Party Transaction [Line Items]
Grant of restricted shares																			5,000
Restricted Stock Units (RSUs) [Member] | Consulting [Member]
Related Party Transaction [Line Items]
Unrecognized expense																						$ 68,033
Restricted Stock Units (RSUs) [Member] | Mr. Robin Ross [Member]
Related Party Transaction [Line Items]
Stock award						100,000
Fair value, per share	$ 3.32																			$ 3.32
Grant date value																				$ 332,000
Restricted shares, vesting rate						25%
Stock based compensation																				21,890	0
Unrecognized expense	$ 310,110																			310,110
Restricted Stock Units (RSUs) [Member] | Chief Financial Officer [Member]
Related Party Transaction [Line Items]
Stock award			10,000
Fair value, per share			$ 3.13
Grant date value			$ 31,300
Restricted shares, vesting rate			100%
Stock based compensation																				1,720	$ 0
Unrecognized expense	29,580																			29,580
Restricted Stock [Member] | Mr Peterson [Member]
Related Party Transaction [Line Items]
Stock award									50,000
Grant date value									$ 271,000
Restricted shares, vesting rate									25%
Fair value of grant date per share									$ 5.40
Restricted Stock [Member] | Mr Peterson [Member] | 2022 Equity Incentive Plan [Member]
Related Party Transaction [Line Items]
Grant of restricted shares								50,000
Grant of restricted shares								50,000
Common Stock [Member]
Related Party Transaction [Line Items]
Issuance of common stock for cash, net, shares					12,500									625			20,000				20,000
Common stock, par value, per share																	$ 0.0001							$ 0.0001	$ 0.0001	$ 0.0001
Shares issued, price per share														$ 40			$ 20							$ 24.20	$ 17.60	$ 42
Aggregate fair value					$ 43,800																$ 2
Stock award																					106,250
Grant date value																					$ 11
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]
Related Party Transaction [Line Items]
Issuance of common stock for cash, net, shares											21,250
Common stock, par value, per share											$ 0.0001
Shares issued, price per share											$ 12.80
Aggregate fair value											$ 273,275
McCool Ranch Purchase Agreement [Member]
Related Party Transaction [Line Items]
Payment of execution										$ 100,000					100,000
Obligation to pay										400,000					400,000						400,000
Payment for restarting production operation										$ 284,000					$ 284,000
Six Employee Agreement [Member] | Restricted Stock Units (RSUs) [Member]
Related Party Transaction [Line Items]
Aggregate fair value																$ 1,505,000
Fair value, per share																$ 43
Restricted shares, vesting rate																25%
Stock based compensation																				753,188	$ 440,219
Unrecognized expense	311,593																			$ 311,593
Grant of restricted shares																35,000
Trio LLC [Member]
Related Party Transaction [Line Items]
Working interest															21.91832%						21.91832%
Trio LLC [Member] | McCool Ranch Purchase Agreement [Member]
Related Party Transaction [Line Items]
Working interest										21.91832%					21.91832%						21.91832%
South Salinas Project [Member]
Related Party Transaction [Line Items]
Working interest percentage																				3.80%
Due to operators	128,200														$ 21,651					$ 128,200	$ 21,651
Operators [Member] | McCool Ranch Purchase Agreement [Member]
Related Party Transaction [Line Items]
Payable to related party	$ 116,000																			116,000
Restricted Share Issued to Executives and Employees [Member] | Restricted Stock Units (RSUs) [Member] | Executives [Member]
Related Party Transaction [Line Items]
Stock based compensation																				$ 155,498	$ 161,700
Restricted Share Issued to Executives and Employees [Member] | Restricted Stock Units (RSUs) [Member] | Executives [Member] | 2022 Equity Incentive Plan [Member]
Related Party Transaction [Line Items]
Issuance of common stock for cash, net, shares																		55,000
Aggregate fair value																		$ 323,400
Fair value, per share																			$ 5.88
Related Party [Member] | Mr Peterson [Member]
Related Party Transaction [Line Items]
Short term debt								$ 125,000
Unsecured debt								$ 125,000

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)

1 Months Ended

12 Months Ended

Oct. 31, 2024 USD ($) a $ / shares

Dec. 29, 2023 USD ($) $ / shares shares

Nov. 10, 2023 USD ($) a

Oct. 04, 2023 $ / shares shares

Apr. 20, 2023 $ / shares shares

Jul. 28, 2022 USD ($)

Jul. 11, 2022 USD ($)

Sep. 30, 2024 USD ($) a

Apr. 30, 2023 shares

Mar. 31, 2023 USD ($) a

Oct. 31, 2024 USD ($) a $ / shares

Oct. 31, 2023 USD ($) $ / shares

Sep. 09, 2024 $ / shares

Feb. 26, 2024 $ / shares

Oct. 16, 2023 $ / shares

Oct. 31, 2022 USD ($)

Loss Contingencies [Line Items]

Annual retainer, additional

$ 267,659

$ 3,341

Share price | $ / shares

$ 3.60

$ 5.40

Common stock, par value | $ / shares

$ 0.0001

$ 0.0001

$ 0.0001

$ 0.0001

Warrant [Member]

Loss Contingencies [Line Items]

Issuance of common stock for cash, net, shares | shares

5,000

Debt Instrument, Term

5 years

Share price | $ / shares

$ 66

IPO [Member]

Loss Contingencies [Line Items]

Directors fees

$ 223,170

$ 156,154

Issuance of common stock for cash, net, shares | shares

18,750

Director [Member]

Loss Contingencies [Line Items]

Annual retainer, additional

$ 50,000

Board Committee [Member]

Loss Contingencies [Line Items]

Annual retainer, additional

$ 10,000

Advisors [Member]

Loss Contingencies [Line Items]

Non refundable payment

$ 25,000

Agreement with advisors, description

i) a cash fee 7.5% of the aggregate proceeds raised in the sale and ii) warrants to purchase a number of common shares equal to 5% of the number of common shares initially issuable upon conversion of each note tranche; warrants to purchase 4,167 and 2,750 common shares with exercise prices of $26.40 and $11.00 for the first and second tranches, respectively, were issued to Spartan as of January 31, 2024. Such warrants may be exercised beginning 6 months after issuance until four- and one-half years thereafter.

the Company’s initial public offering (“IPO”), a cash fee of 7.5%, warrants to purchase a number of common shares equal to 5% of the aggregate number of common shares placed in the IPO and reimbursement of other expenses.

Shares issued warrants to purchase | shares

2,750

4,167

Exercise price of warrants or rights | $ / shares

$ 11

$ 26.40

ARLO Agreement [Member]

Loss Contingencies [Line Items]

Area of land | a

960

Percentage of interest

20%

Payments to acquire loans and lease

$ 2,000,000

ARLO Agreement [Member] | Minimum [Member]

Loss Contingencies [Line Items]

Payments to acquire loans and lease

$ 500,000

Amended AR Agreement [Member]

Loss Contingencies [Line Items]

Amount agreed to fund

$ 200,000

Amended ARLO Agreement [Member]

Loss Contingencies [Line Items]

Area of land | a

960

Percentage of interest

2%

17.75%

Total purchase price of lease

$ 500,000

Proceeds from lease payments

$ 225,000

Percentage of interest to acquire infrastructure

2.25%

2.25%

Stock Issued During Period, Value, Stock Options Exercised

$ 1,775,000

Working interest percentage

17.75%

Proceeds from Stock Options Exercised

$ 1,775,000

Parcel 1 [Member]

Loss Contingencies [Line Items]

Area of land | a

480

480

Parcel 2 [Member]

Loss Contingencies [Line Items]

Area of land | a

320

320

Leasehold [Member]

Loss Contingencies [Line Items]

Area of land | a

800

800

First Aforementioned [Member] | Unproved Property Lease [Member]

Loss Contingencies [Line Items]

Area of land | a

8,417

8,417

Non refundable payment

$ 252,512

Second Aforementioned [Member] | Unproved Property Lease [Member]

Loss Contingencies [Line Items]

Area of land | a

160

160

Delay rental payments

$ 30

$ 30

First Group [Member] | Unproved Property Lease [Member]

Loss Contingencies [Line Items]

Area of land | a

360

Lease, term

20 years

Payments for rent

$ 25

Second Group [Member] | Unproved Property Lease [Member]

Loss Contingencies [Line Items]

Area of land | a

307.75

Lease, term

20 years

Payments for rent

$ 30

SCHEDULE OF DEFERRED TAX ASSETS

SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)	Oct. 31, 2024	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Net operating loss carry forwards	$ 1,699,000	$ 1,095,000
Total deferred tax asset	1,699,000	1,095,000
Valuation allowance	(1,699,000)	(1,095,000)
Deferred tax asset, net

SCHEDULE OF EFFECTIVE FEDERAL I

SCHEDULE OF EFFECTIVE FEDERAL INCOME TAX RATE RECONCILIATION (Details)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Federal statutory blended income tax rates	(21.00%)	(21.00%)
State statutory income tax rate, net of federal benefit
Change in valuation allowance	21%	21%
Effective tax rate

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Income Tax Disclosure [Abstract]
Operating loss Carryforwards	$ 1,699,000	$ 1,095,000
Valuation allowance deferred tax assets, Increase decrease	$ 604,000	$ 298,000

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Oct. 31, 2024	Oct. 31, 2023
Debt Disclosure [Abstract]
Convertible note, net of discounts		$ 1,217,597
Promissory notes, net of discounts	742,852
Note payable – related party	135,000
Total Notes payable	$ 877,852	$ 1,217,597

NOTES PAYABLE (Details Narrativ

NOTES PAYABLE (Details Narrative)																																				1 Months Ended			12 Months Ended
	May 30, 2025 USD ($)	Apr. 30, 2025 USD ($)	Mar. 30, 2025 USD ($)	Feb. 28, 2025 USD ($)	Jan. 30, 2025 USD ($)	Oct. 31, 2024 USD ($) $ / shares shares	Oct. 30, 2024 USD ($) $ / shares shares	Oct. 28, 2024 USD ($)	Oct. 18, 2024 USD ($) $ / shares shares	Oct. 11, 2024 USD ($) $ / shares shares	Oct. 01, 2024 USD ($) $ / shares shares	Sep. 30, 2024 USD ($)	Sep. 26, 2024 USD ($) $ / shares shares	Sep. 09, 2024 $ / shares shares	Aug. 06, 2024 USD ($) $ / shares	Aug. 01, 2024 USD ($)	Jun. 27, 2024 USD ($) $ / shares shares	May 31, 2024 USD ($)	Apr. 24, 2024 USD ($) $ / shares shares	Apr. 15, 2024 USD ($) $ / shares shares	Apr. 02, 2024 USD ($) $ / shares shares	Mar. 27, 2024 USD ($) $ / shares	Mar. 26, 2024 USD ($) shares	Mar. 22, 2024 USD ($) $ / shares shares	Feb. 16, 2024 USD ($) $ / shares shares	Feb. 05, 2024 USD ($) $ / shares shares	Feb. 02, 2024 USD ($) $ / shares shares	Feb. 01, 2024 USD ($) $ / shares shares	Jan. 12, 2024 USD ($) $ / shares shares	Jan. 02, 2024 USD ($) $ / shares shares	Dec. 29, 2023 USD ($) $ / shares shares	Dec. 18, 2023 USD ($) $ / shares shares	Oct. 31, 2023 USD ($)	Oct. 04, 2023 USD ($) $ / shares shares	Apr. 20, 2023 $ / shares shares	Dec. 31, 2023 USD ($)	Oct. 31, 2023 USD ($)	Dec. 31, 2022 shares	Oct. 31, 2024 USD ($) $ / shares	Oct. 31, 2023 USD ($) shares	Dec. 30, 2024 USD ($)	Nov. 30, 2024 USD ($)	Aug. 14, 2024	Oct. 16, 2023 $ / shares
Short-Term Debt [Line Items]
Proceeds from convertible debt																																							$ 550,000	$ 2,000,000
Debt conversion price | $ / shares							$ 2.58				$ 3.66		$ 3.38								$ 3.40			$ 2	$ 2.60			$ 4.80	$ 5.80		$ 6.20	$ 6.80
Debt issuance costs																																							$ 259,903	350,320
Share price | $ / shares														$ 3.60																														$ 5.40
Expected term																																							5 years
Expected volatility rate																																							137.10%
Expected dividend rate																																							0%
Debt conversion converted instrument rate																			100%
Debt instrument conversion amount							$ 98,422				$ 62,830		$ 103,091
Debt instrument conversion shares | shares							38,150				17,167		30,520
Description of amendment to first tranche note																										i) a reduction of the floor price of the conversion price from $7.00 to $3.00, ii) the issuance of additional 119,796 shares of common stock (as noted above) to the investor in lieu of the Company’s obligation to pay cash installments under the First Tranche Note, and iii) a new obligation of the Company to request acceleration of monthly payments in installments of $250,000 as soon as possible to repay the remaining $1,000,000 principal balance of the First Tranche Note, with the investor converting and selling shares subject to a) the beneficial ownership limitation of 4.99% and b) market prices of the Company’s common stock being at or above the floor price of $3.00.
Convertible note, net of discounts																																	$ 1,217,597				$ 1,217,597			1,217,597
Gross Proceeds																																							250,666
Cash payments																																							352,767	1,472,512
Unsecured debt																							$ 125,000
Amortization of debt discount																																							2,092,671	473,240
Chief Executive Officer [Member]
Short-Term Debt [Line Items]
Gross Proceeds																							1,000,000
Short term debt																							$ 125,000
Interest rate																							10%
Shares vested | shares																							50,000
Michael L Peterson [Member]
Short-Term Debt [Line Items]
Debt instrument face amount						135,000																											0				0		135,000	0
Gross Proceeds																							$ 1,000,000
Short term debt																							125,000
Unsecured debt																							$ 125,000
Interest rate																							10%
Gross proceeds								$ 5,000					$ 5,000
Accrued Interest						$ 7,586																											0				0		7,586	$ 0
Warrant [Member]
Short-Term Debt [Line Items]
Share price | $ / shares																																			$ 66
Issuance of common stock for cash, net, shares | shares																																			5,000
Common Stock [Member]
Short-Term Debt [Line Items]
Issuance of common stock for cash, net, shares | shares														12,500																					625			20,000		20,000
New Modified Terms [Member] | Warrant [Member]
Short-Term Debt [Line Items]
Net of equity issuance costs																															$ 100,000
Minimum [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares																										$ 3
Debt conversion converted instrument rate																			45%
Maximum [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares																						$ 1.42340				7
Second Tranche [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares																										$ 3.60	$ 3.40
Debt instrument conversion amount																										$ 339,334	$ 323,094
Debt instrument conversion shares | shares																										94,417	94,417
Gain on extinguishment of debt																										$ 64,334	$ 48,094
First Tranche [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares																				$ 12.60								$ 4.80
Debt instrument conversion amount																				$ 221,449								$ 574,779
Issuance of common stock for cash, net, shares | shares																				17,576								119,796
Measurement Input, Share Price [Member] | Original Issue Terms [Member]
Short-Term Debt [Line Items]
Share price | $ / shares																															$ 6.20
Measurement Input, Share Price [Member] | New Modified Terms [Member]
Short-Term Debt [Line Items]
Share price | $ / shares																															6.20
Measurement Input, Exercise Price [Member] | Original Issue Terms [Member]
Short-Term Debt [Line Items]
Exercise price | $ / shares																															24
Measurement Input, Exercise Price [Member] | New Modified Terms [Member]
Short-Term Debt [Line Items]
Exercise price | $ / shares																															$ 10
Measurement Input, Expected Term [Member] | Original Issue Terms [Member]
Short-Term Debt [Line Items]
Expected term																															5 years
Measurement Input, Expected Term [Member] | New Modified Terms [Member]
Short-Term Debt [Line Items]
Expected term																															5 years
Measurement Input, Option Volatility [Member] | Original Issue Terms [Member]
Short-Term Debt [Line Items]
Expected volatility rate																															137.10%
Measurement Input, Option Volatility [Member] | New Modified Terms [Member]
Short-Term Debt [Line Items]
Expected volatility rate																															137.10%
Measurement Input, Expected Dividend Rate [Member] | Original Issue Terms [Member]
Short-Term Debt [Line Items]
Expected dividend rate																															0%
Measurement Input, Expected Dividend Rate [Member] | New Modified Terms [Member]
Short-Term Debt [Line Items]
Expected dividend rate																															0%
Measurement Input, Discount Rate [Member] | Original Issue Terms [Member]
Short-Term Debt [Line Items]
Warrants and rights outstanding measurement input																															3.84
Measurement Input, Discount Rate [Member] | New Modified Terms [Member]
Short-Term Debt [Line Items]
Warrants and rights outstanding measurement input																															3.84
June 2024 SPA [Member]
Short-Term Debt [Line Items]
Warrants to purchase | shares																	37,231
Aggregate relative fair value																	$ 257,701
Issuance of common stock for cash, net, shares | shares																	74,461
June 2024 SPA [Member] | Measurement Input, Share Price [Member]
Short-Term Debt [Line Items]
Share price | $ / shares																	$ 6
June 2024 SPA [Member] | Measurement Input, Exercise Price [Member]
Short-Term Debt [Line Items]
Exercise price | $ / shares																	$ 7.90500
June 2024 SPA [Member] | Measurement Input, Expected Term [Member]
Short-Term Debt [Line Items]
Expected term																	5 years
June 2024 SPA [Member] | Measurement Input, Option Volatility [Member]
Short-Term Debt [Line Items]
Expected volatility rate																	132.52%
June 2024 SPA [Member] | Measurement Input, Expected Dividend Rate [Member]
Short-Term Debt [Line Items]
Expected dividend rate																	0%
June 2024 SPA [Member] | Measurement Input, Discount Rate [Member]
Short-Term Debt [Line Items]
Discount rate																	4.29
Convertible Notes Payable [Member]
Short-Term Debt [Line Items]
Debt instrument face amount																					$ 257,500			$ 42,917	$ 42,917			$ 91,965	$ 125,000		$ 125,000	$ 125,000
Proceeds from convertible debt																																				$ 2,371,500	2,371,500
Debt conversion price | $ / shares																													$ 5.80		$ 6.20	$ 6.80
Debt conversion converted instrument rate						103%																							103%
Debt instrument conversion amount																													$ 128,750		$ 128,750	$ 128,750
Debt instrument conversion shares | shares																					257,500			42,917	42,917			91,965	18,393		18,393	18,393
Cash payments made to investor																					$ 32,247			$ 32,247	$ 32,247			$ 32,247	$ 49,935		$ 35,837	$ 36,698
Gain on extinguishment of debt																													30,510		$ 24,873	36,770
Convertible note, net of discounts																																	1,217,597				1,217,597			$ 1,217,597
Interest expense																																							1,063,372	40,547
Convertible Notes Payable [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Debt instrument face amount																										$ 275,000	$ 275,000
Debt conversion converted instrument rate																										103%	103%
Debt instrument conversion amount																										$ 283,250	$ 283,250
Convertible Notes Payable [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Debt instrument face amount																					$ 750,000			125,000	125,000			625,000
Debt conversion converted instrument rate																					103%
Debt instrument conversion amount																					$ 772,500			128,750	128,750			643,750
Gain on extinguishment of debt																					131,165			180,566	20,547			391,447
Convertible Notes Payable [Member] | October 2023 SPA [Member]
Short-Term Debt [Line Items]
Debt instrument face amount																																		$ 3,500,000
Proceeds from convertible debt																														$ 550,000				$ 2,000,000
Original issue discount, rate																														7%				7%
Debt discount																														$ 38,500				$ 140,000
Debt issuance costs																														90,978				350,320
Net proceeds																														$ 421,000				$ 1,500,000
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Second Tranche [Member] | Minimum [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares																															$ 24
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Second Tranche [Member] | Maximum [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares																															10
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Share Price [Member]
Short-Term Debt [Line Items]
Share price | $ / shares																														$ 6.40				$ 11
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Share Price [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Share price | $ / shares																														6.40	6.40
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Share Price [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Share price | $ / shares																															11
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Exercise Price [Member]
Short-Term Debt [Line Items]
Exercise price | $ / shares																														10				$ 24
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Exercise Price [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Exercise price | $ / shares																														$ 10	11
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Exercise Price [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Exercise price | $ / shares																															$ 26.40
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Term [Member]
Short-Term Debt [Line Items]
Expected term																														5 years				5 years
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Term [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Expected term																														5 years	5 years
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Term [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Expected term																															5 years
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Option Volatility [Member]
Short-Term Debt [Line Items]
Expected volatility rate																														137.10%				137.10%
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Option Volatility [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Expected volatility rate																														137.10%	137.10%
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Option Volatility [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Expected volatility rate																															137.10%
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Dividend Rate [Member]
Short-Term Debt [Line Items]
Expected dividend rate																														0%				0%
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Dividend Rate [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Expected dividend rate																														0%	0%
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Dividend Rate [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Expected dividend rate																															0%
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Discount Rate [Member]
Short-Term Debt [Line Items]
Discount rate																														3.93				4.72
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Discount Rate [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Discount rate																														3.93	3.93
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Discount Rate [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Discount rate																															4.72
Convertible Notes Payable [Member] | October 2023 SPA [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Proceeds from convertible debt																																		$ 2,000,000
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Proceeds from convertible debt																																		1,500,000
Senior Secured Convertible Promissory Note [Member]
Short-Term Debt [Line Items]
Debt instrument face amount																			$ 800,000
Original issue discount, rate																			10%
Debt discount																			$ 80,000
Senior Secured Convertible Promissory Note [Member] | October 2023 SPA [Member]
Short-Term Debt [Line Items]
Debt instrument face amount																																		$ 2,000,000
Warrants to purchase | shares																														22,279				43,336
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares																																		$ 24
Debt conversion price | $ / shares																																		24
Debt instrument floor price | $ / shares																																		$ 7
Aggregate relative fair value																														$ 98,708				$ 332,630
Senior Secured Convertible Promissory Note [Member] | October 2023 SPA [Member] | Second Tranche [Member]
Short-Term Debt [Line Items]
Warrants to purchase | shares																														22,279	2,750
Aggregate relative fair value																														$ 98,708	$ 14,753
Senior Secured Convertible Promissory Note [Member] | October 2023 SPA [Member] | First Tranche [Member]
Short-Term Debt [Line Items]
Warrants to purchase | shares																															4,167
Aggregate relative fair value																															$ 38,029
Senior Secured Convertible Promissory Note [Member] | June 2024 SPA [Member]
Short-Term Debt [Line Items]
Debt instrument face amount																	$ 400,000
Original issue discount, rate																	10%
Convertible Notes Payable One [Member]
Short-Term Debt [Line Items]
Debt instrument conversion amount																					$ 881,165			$ 84,117	$ 113,300			$ 441,428	$ 105,575		$ 114,036	$ 125,072
March 2024 Debt Financing [Member]
Short-Term Debt [Line Items]
Debt instrument face amount							$ 29,610					$ 118,440										$ 211,500
Original issue discount, rate																						13%
Debt discount																						$ 27,000
Convertible note, net of discounts						67,514																											0				0		67,514	0
Interest expense																																							51,064	0
Gross Proceeds																						184,500
Net Proceeds																						$ 164,500
Interest rate																						12%
Issuance of shares																						$ 25,380
Debt instrument description																						The Investor Note contains provisions constituting an Event of Default (as such term is defined in the March 2024 Investor Note) and, upon an Event of Default, the March 2024 Investor Note will be accelerated and become due and payable in an amount equal to 150% of all amounts due and payable under the March 2024 Investor Note with interest at a default rate of 22% per annum. In addition, upon an Event of Default, the March 2024 Investor has the right to convert all or any outstanding amount of the March Investor Note into shares of the Company’s common stock at a conversion price equal to the greater of (i) 75% of the Market Price (as such term is defined in the March 2024 Investor Note) or (ii) the conversion floor price, which is $1.42340 (the “Floor Price”); provided, however, that the Floor Price shall not apply after October 5, 2024, and thereafter, the conversion price will be 75% of the Market Price. Issuance of shares of common stock to the March 2024 Investor is subject to certain beneficial ownership limitations and not more than 19.99% of the shares of common stock outstanding on March 29, 2024 may be issued upon conversion of the March 2024 Investor Note. The conversion price is also subject to certain adjustments or other terms in the event of (i) mergers, consolidations or recapitalization events or (ii) certain distributions made to holders of shares of common stock.
Cash payments							$ 29,610					$ 118,440
March 2024 Debt Financing [Member] | Forecast [Member]
Short-Term Debt [Line Items]
Debt instrument face amount					$ 29,610																																				$ 29,610	$ 29,610
March 2024 Debt Financing [Member] | Minimum [Member]
Short-Term Debt [Line Items]
Original issue discount, rate																						3%
April 2024 Debt Financing [Member]
Short-Term Debt [Line Items]
Debt instrument face amount						0													$ 720,000														0				0		0	0
Debt conversion price | $ / shares									$ 3		$ 3.44								$ 5
Debt issuance costs																			$ 56,000
Share price | $ / shares									$ 3.10		$ 3.66
Debt instrument conversion amount									$ 77,450		$ 729,405
Debt instrument conversion shares | shares									25,000		224,291
Issuance of common stock for cash, net, shares | shares																			37,500
Gross Proceeds																			$ 1,000,000
Net Proceeds																		$ 5,000,000	$ 664,000
Interest rate																			15%																								15%
Issuance of shares																			$ 366,000
Percentage of outstanding shares																		50%
Maturity Date																			Aug. 16, 2024
Debt issuance costs																			$ 136,000
Periodic payment of debt									$ 75,000		$ 682,031
Interest paid						816,445					7,031																						0
Loss on conversion									$ 2,450		47,373
April 2024 Debt Financing [Member] | Two Cash Payment [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares															$ 25,000
April 2024 Debt Financing [Member] | Commitment Shares [Member]
Short-Term Debt [Line Items]
Issuance of common stock for cash, net, shares | shares																			75,000
April 2024 Debt Financing [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares																			$ 9.80
April 2024 Debt Financing [Member] | Minimum [Member]
Short-Term Debt [Line Items]
Issuance of shares																			$ 301,500
April 2024 Debt Financing [Member] | Minimum [Member] | Common Stock [Member]
Short-Term Debt [Line Items]
Debt conversion price | $ / shares																			$ 8
June 2024 Debt Financing [Member]
Short-Term Debt [Line Items]
Debt instrument face amount						$ 88,888					$ 50,000		$ 88,888																				0				0		$ 88,888	0
Debt conversion price | $ / shares						$ 2.58				$ 3.38	$ 3.66		$ 3.38				$ 7.90500																						$ 2.58
Debt instrument floor price | $ / shares																	$ 2.40
Debt instrument conversion amount						$ 91,556				$ 7,838	$ 51,500		$ 91,556
Debt instrument conversion shares | shares						38,150					17,167		30,520
Gain on extinguishment of debt						$ 9,534					$ 12,830		$ 14,203
Issuance of common stock for cash, net, shares | shares										2,317
Gross Proceeds																	$ 720,000
Net Proceeds																	$ 676,200
Debt instrument description																	The June 2024 Notes are initially convertible into shares of Common Stock (the “June 2024 Conversion Shares”) at a conversion price of $7.90500 per share, subject to certain adjustments (the “June 2024 Notes Conversion Price”), provided that the June 2024 Conversion Price shall not be reduced below $2.40 (the “June 2024 Floor Price”), and provided further that, subject to the applicable rules of the NYSE American, the Company may lower the June 2024 Floor Price at any time upon written notice to the June 2024 Investors. The June 2024 Notes do not bear any interest, except in the case of an Event of Default (as such term is defined in the June 2024 Notes), and the June 2024 Notes mature on June 27, 2025. Upon the occurrence of any Event of Default, interest shall accrue on the June 2024 Notes at a rate equal to 10% per annum or, if less, the highest amount permitted by law.
Percentage of total principal amount																	103%
Percentage of pre-payment premium																	5%
Amortization of debt discount																																	0
June 2024 Debt Financing [Member] | June 2024 SPA [Member]
Short-Term Debt [Line Items]
Debt instrument face amount																	$ 360,000
Original issue discount, rate																	10%
June 2024 SPA [Member]
Short-Term Debt [Line Items]
Warrants to purchase | shares																	37,231
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares																	$ 7.90500
Aggregate relative fair value																	$ 257,701
Issuance of common stock for cash, net, shares | shares																	74,461
June 2024 SPA [Member] | Measurement Input, Share Price [Member]
Short-Term Debt [Line Items]
Share price | $ / shares																	$ 6
June 2024 SPA [Member] | Measurement Input, Exercise Price [Member]
Short-Term Debt [Line Items]
Exercise price | $ / shares																	$ 7.90500
June 2024 SPA [Member] | Measurement Input, Expected Term [Member]
Short-Term Debt [Line Items]
Expected term																	5 years
June 2024 SPA [Member] | Measurement Input, Option Volatility [Member]
Short-Term Debt [Line Items]
Expected volatility rate																	132.52%
June 2024 SPA [Member] | Measurement Input, Expected Dividend Rate [Member]
Short-Term Debt [Line Items]
Expected dividend rate																	0%
June 2024 SPA [Member] | Measurement Input, Discount Rate [Member]
Short-Term Debt [Line Items]
Discount rate																	4.29
June Two Thousand Twenty Four Debt Financing Net [Member]
Short-Term Debt [Line Items]
Debt instrument conversion amount						98,422					$ 62,830		$ 103,091
June Two Thousand Twenty Four Debt Financing One [Member]
Short-Term Debt [Line Items]
Debt instrument face amount						322,419																																	$ 322,419
Amortization of debt discount						131,696
August One Two Thousand And Twenty Four Financing [Member]
Short-Term Debt [Line Items]
Debt instrument face amount						128,588										$ 152,000																	0				$ 0		128,588	$ 0
Debt discount																18,000
Gross Proceeds																134,000
Net Proceeds																$ 110,625
Interest rate																12%
Maturity Date																May 30, 2025
Amortization of debt discount						17,963																											0
Debt discount percentage																11.80%
Debt prepayment discount percentage																3%
Interest paid																$ 18,240
August One Two Thousand And Twenty Four Financing [Member] | Subsequent Event [Member]
Short-Term Debt [Line Items]
Periodic payment of debt	$ 21,280	$ 21,280	$ 21,280	$ 21,280	85,120
August Six Two Thousand And Twenty Four Financing [Member]
Short-Term Debt [Line Items]
Debt instrument face amount						224,327									$ 255,225																								$ 224,327
Debt discount															30,225
Gross Proceeds															225,000
Net Proceeds															$ 199,250
Interest rate															12%
Maturity Date															May 30, 2025
Amortization of debt discount						$ 25,077																											$ 0
Debt discount percentage															11.80%
Debt prepayment discount percentage															3%
Interest paid															$ 30,627
August Six Two Thousand And Twenty Four Financing [Member] | Subsequent Event [Member]
Short-Term Debt [Line Items]
Periodic payment of debt	$ 35,731.50	$ 35,731.50	$ 35,731.50	$ 35,731.50	$ 142,926

SCHEDULE OF WARRANT ACTIVITY (D

SCHEDULE OF WARRANT ACTIVITY (Details) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Equity [Abstract]
Number of Warrants, Outstanding, Beginning	88,336
Weighted Average Exercise Price, Beginning	$ 22.35
Intrinsic Value, Beginning	$ 211,200
Number of Warrants, Issued	103,658	238,803
Weighted Average Exercise Price, Issued	$ 9.18	$ 20.77
Weighted Average Remaining Life in Years	4 years 6 months	3 years 1 month 6 days
Number of Warrants, Exercised		(145,065)
Weighted Average Exercise Price, Exercised		$ 20.51
Number of Warrants, Cancelled
Weighted Average Exercise Price, Cancelled
Number of Warrants, Expired		(5,402)
Weighted Average Exercise Price, Expired
Weighted Average Remaining Life in Years	3 years 9 months 18 days	3 years 10 months 24 days
Number of Warrants, Exercised		145,065
Number of Warrants, Expired		5,402
Number of Warrants, Outstanding, Ending	191,994	88,336
Weighted Average Exercise Price, Ending	$ 15.24	$ 22.35
Intrinsic Value, Ending	$ 47,160	$ 211,200
Number of Warrants, Outstanding, Exercisable	191,994
Weighted Average Exercise Price, Exercisable	$ 15.24
Weighted Average Remaining Life in Years, Exercisable	3 years 9 months 18 days
Intrinsic Value, Exercisable Ending	$ 47,160

SCHEDULE OF OUTSTANDING AND EXE

SCHEDULE OF OUTSTANDING AND EXERCISABLE WARRANTS (Details) - Warrant [Member]	12 Months Ended
	Oct. 31, 2024 $ / shares shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Number of Shares	191,994
Warrants Exercisable, Weighted Average Remaining Life in Years	3 years 9 months 18 days
Warrants Exercisable, Number of Shares	191,994
Exercise Price Range One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Exercise Price | $ / shares	$ 0.20
Warrants Outstanding, Number of Shares	20,000
Warrants Exercisable, Weighted Average Remaining Life in Years	3 years 6 months
Warrants Exercisable, Number of Shares	20,000
Exercise Price Range Two [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Exercise Price | $ / shares	$ 30
Warrants Outstanding, Number of Shares	20,000
Warrants Exercisable, Weighted Average Remaining Life in Years	1 month 6 days
Warrants Exercisable, Number of Shares	20,000
Exercise Price Range Three [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Exercise Price | $ / shares	$ 66
Warrants Outstanding, Number of Shares	5,000
Warrants Exercisable, Weighted Average Remaining Life in Years	3 years 6 months
Warrants Exercisable, Number of Shares	5,000
Exercise Price Range Four [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Exercise Price | $ / shares	$ 24
Warrants Outstanding, Number of Shares	43,336
Warrants Exercisable, Weighted Average Remaining Life in Years	3 years 10 months 24 days
Warrants Exercisable, Number of Shares	43,336
Exercise Price Range Five [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Exercise Price | $ / shares	$ 26.40
Warrants Outstanding, Number of Shares	4,167
Warrants Exercisable, Weighted Average Remaining Life in Years	3 years 10 months 24 days
Warrants Exercisable, Number of Shares	4,167
Exercise Price Range Six [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Exercise Price | $ / shares	$ 10
Warrants Outstanding, Number of Shares	22,279
Warrants Exercisable, Weighted Average Remaining Life in Years	4 years 2 months 12 days
Warrants Exercisable, Number of Shares	22,279
Exercise Price Range Seven [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Exercise Price | $ / shares	$ 11
Warrants Outstanding, Number of Shares	2,750
Warrants Exercisable, Weighted Average Remaining Life in Years	4 years 2 months 12 days
Warrants Exercisable, Number of Shares	2,750
Exercise Price Range Eight [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants Outstanding, Exercise Price | $ / shares	$ 7.91
Warrants Outstanding, Number of Shares	74,462
Warrants Exercisable, Weighted Average Remaining Life in Years	4 years 8 months 12 days
Warrants Exercisable, Number of Shares	74,462

SCHEDULE OF STOCK OPTION ACTIVI

SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($)	12 Months Ended
	Oct. 31, 2024	Oct. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted Average Exercise Price, Beginning	$ 22.35
Weighted Average Exercise Price, Issued	9.18	$ 20.77
Intrinsic Value, Issued		$ 1,800
Weighted Average Exercise Price, Exercised		$ 20.51
Weighted Average Exercise Price, Expired
Weighted Average Exercise Price, Ending	$ 15.24	$ 22.35
Number of Warrants, Outstanding, Exercisable	191,994
Weighted Average Exercise Price, Exercisable	$ 15.24
Weighted Average Remaining Life in Years, Exercisable	3 years 9 months 18 days
Intrinsic Value, Exercisable Ending	$ 47,160
Share-Based Payment Arrangement, Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Options, Outstanding Beginning	6,000
Weighted Average Exercise Price, Beginning	$ 10.46
Intrinsic Value, Beginning	$ 1,800
Number of Options, Issued		6,000
Weighted Average Exercise Price, Issued		$ 10.46
Weighted Average Remaining Life in Years		4 years 9 months 18 days
Intrinsic Value, Issued
Weighted Average Remaining Life in Years	3 years 9 months 18 days	4 years 9 months 18 days
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Number of Options, Cancelled
Weighted Average Exercise Price, Expired
Number of Options, Expired
Number of Options, Outstanding Ending	6,000	6,000
Weighted Average Exercise Price, Ending	$ 10.46	$ 10.46
Intrinsic Value, Ending		$ 1,800
Number of Warrants, Outstanding, Exercisable	6,000
Weighted Average Exercise Price, Exercisable	$ 10.46
Weighted Average Remaining Life in Years, Exercisable	3 years 9 months 18 days
Intrinsic Value, Exercisable Ending

SCHEDULE OF OUTSTANDING AND E_2

SCHEDULE OF OUTSTANDING AND EXERCISABLE OPTIONS (Details) - Share-Based Payment Arrangement, Option [Member]	12 Months Ended
	Oct. 31, 2024 $ / shares shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding, Number of Shares	6,000
Options Exercisable, Weighted Average Remaining Life in Years	3 years 9 months 18 days
Options Exercisable, Number of Shares	6,000
Exercise Price Range One [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding, Exercise Price | $ / shares	$ 10.46
Options Outstanding, Number of Shares	6,000
Options Exercisable, Weighted Average Remaining Life in Years	3 years 9 months 18 days
Options Exercisable, Number of Shares	6,000

SCHEDULE OF ASSUMPTIONS USED IN

SCHEDULE OF ASSUMPTIONS USED IN BLACK-SCHOLES VALUATION METHOD FOR OPTIONS (Details)	12 Months Ended
	Oct. 31, 2024
Equity [Abstract]
Risk free interest rate	4.36%
Expected term (years)	5 years
Expected volatility	137.10%
Expected dividends	0%

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative)																																						1 Months Ended			12 Months Ended
	Oct. 31, 2024 USD ($) $ / shares shares	Oct. 30, 2024 USD ($) $ / shares shares	Oct. 18, 2024 USD ($) $ / shares shares	Oct. 11, 2024 USD ($) $ / shares shares	Oct. 01, 2024 USD ($) $ / shares shares	Sep. 26, 2024 USD ($) $ / shares shares	Sep. 09, 2024 USD ($) $ / shares shares	Jun. 27, 2024 USD ($) $ / shares shares	Apr. 29, 2024 USD ($) $ / shares shares	Apr. 24, 2024 USD ($) $ / shares shares	Apr. 16, 2024 USD ($) $ / shares shares	Apr. 15, 2024 USD ($) $ / shares shares	Apr. 02, 2024 USD ($) $ / shares shares	Mar. 26, 2024 USD ($) $ / shares shares	Mar. 22, 2024 USD ($) $ / shares shares	Mar. 20, 2024 USD ($) $ / shares shares	Feb. 16, 2024 USD ($) $ / shares shares	Feb. 05, 2024 USD ($) $ / shares shares	Feb. 02, 2024 USD ($) $ / shares shares	Feb. 01, 2024 USD ($) $ / shares shares	Jan. 12, 2024 USD ($) $ / shares shares	Jan. 02, 2024 USD ($) $ / shares shares	Dec. 29, 2023 USD ($) $ / shares shares	Dec. 18, 2023 USD ($) $ / shares shares	Nov. 11, 2023 USD ($) $ / shares shares	Oct. 31, 2023 USD ($) $ / shares shares	Oct. 16, 2023 USD ($) $ / shares shares	Oct. 04, 2023 USD ($) $ / shares shares	Sep. 02, 2023 USD ($) $ / shares shares	Aug. 15, 2023 USD ($) $ / shares shares	Jul. 20, 2023 USD ($) $ / shares shares	Jul. 11, 2023 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares shares	Jun. 23, 2023 USD ($) $ / shares shares	May 02, 2023 USD ($) $ / shares shares	May 01, 2023 USD ($) $ / shares shares	Apr. 20, 2023 USD ($) $ / shares shares	Jan. 31, 2024 USD ($)	Apr. 30, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Oct. 31, 2024 USD ($) $ / shares shares	Oct. 31, 2023 USD ($) $ / shares shares	Feb. 26, 2024 $ / shares	Oct. 31, 2022 $ / shares
Accumulated Other Comprehensive Income (Loss) [Line Items]
Aggregate authorized shares | shares	25,000,000																																								25,000,000
Common stock, shares authorized | shares	24,500,000																									24,500,000															24,500,000	24,500,000
Common stock, par value | $ / shares	$ 0.0001																									$ 0.0001															$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized | shares	500,000																									500,000															500,000	500,000
Preferred stock, par value | $ / shares	$ 0.0001																									$ 0.0001															$ 0.0001	$ 0.0001
Gross proceeds																																										$ 738,659
Stock based compensation																																									1,534,667	1,044,261
Issuance of shares, value																																										372,000
Value of stock issued																																										366,659
Resale amendment agreement, description																																	the Company issued a Form S-1/A, which registered for resale (i) up to 157,466 shares of common stock, par value $0.0001 per share which the selling stockholders may acquire upon the exercise of outstanding common warrants and (ii) up to 25,000 shares of common stock, which the selling stockholders may acquire upon the exercise of outstanding pre-funded warrants. Such warrants were issued to the selling stockholders in connection with securities purchase agreements entered into on January 28, 2022 and September 20, 2022. The Company recorded 34,993 shares of common stock that are not exercised but registered in accordance with their common warrant agreements and 25,000 shares of common stock that are not exercised but registered in accordance with their pre-funded warrant agreements upon the filing of this Form S-1/A
Share price | $ / shares							$ 3.60																				$ 5.40
Number of shares grant | shares																											50,000
Number of shares granted fair value																											$ 271,000
Vesting period																											The restricted stock grant vests over a period of two years, with 25% of the shares of restricted stock vesting six months after the Peterson Employment Agreement Effective Date, and the remainder vesting in equal tranches on each of the 12-, 18-, and 24-month anniversary dates of the Peterson Employment Agreement
Stock based compensation																																									$ 267,659	$ 3,341
Conversion of debt into shares | shares		38,150			17,167	30,520
Price at which shares are converted | $ / shares		$ 2.58			$ 3.66	$ 3.38							$ 3.40		$ 2		$ 2.60			$ 4.80	$ 5.80		$ 6.20	$ 6.80
Total amount of shares		$ 98,422			$ 62,830	$ 103,091
Debt conversion converted instrument rate										100%
Cash payment							$ 100,000
Expected term																																									5 years
Expected volatility rate																																									137.10%
Expected dividend rate																																									0%
Options exercise price | $ / shares	$ 15.24																									$ 22.35															$ 15.24	$ 22.35
June 2024 SPA [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares								74,461
Warrants to purchase | shares								37,231
Aggregate relative fair value								$ 257,701
June 2024 SPA [Member] | Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price | $ / shares								$ 6
June 2024 SPA [Member] | Measurement Input, Exercise Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price | $ / shares								$ 7.90500
June 2024 SPA [Member] | Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term								5 years
June 2024 SPA [Member] | Measurement Input, Option Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected volatility rate								132.52%
June 2024 SPA [Member] | Measurement Input, Expected Dividend Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividend rate								0%
June 2024 SPA [Member] | Measurement Input, Discount Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Discount rate								4.29
Convertible Notes Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument face amount													$ 257,500		$ 42,917		$ 42,917			$ 91,965	$ 125,000		$ 125,000	$ 125,000
Conversion of debt into shares | shares													257,500		42,917		42,917			91,965	18,393		18,393	18,393
Price at which shares are converted | $ / shares																					$ 5.80		$ 6.20	$ 6.80
Debt instrument conversion value issued																					$ 105,575		$ 114,036	$ 125,072
Cash payments made to investor													$ 32,247		$ 32,247		$ 32,247			$ 32,247	49,935		35,837	36,698
Gain on extinguishment of debt																					30,510		24,873	36,770
Total amount of shares																					$ 128,750		128,750	128,750
Debt conversion converted instrument rate	103%																				103%
Convertible Notes Payable [Member] | October 2023 SPA [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument face amount																												$ 3,500,000
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price | $ / shares																						$ 6.40						$ 11
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Exercise Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price | $ / shares																						$ 10						$ 24
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term																						5 years						5 years
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Option Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected volatility rate																						137.10%						137.10%
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Dividend Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividend rate																						0%						0%
Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Discount Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Discount rate																						3.93						4.72
Convertible Notes Payable One [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total amount of shares													881,165		84,117		113,300			$ 441,428	$ 105,575		$ 114,036	$ 125,072
April 2024 Debt Financing [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares										37,500
Debt instrument face amount	$ 0									$ 720,000																$ 0															$ 0	$ 0
Share price | $ / shares			$ 3.10		$ 3.66
Conversion of debt into shares | shares			25,000		224,291
Price at which shares are converted | $ / shares			$ 3		$ 3.44					$ 5
Total amount of shares			$ 77,450		$ 729,405
Debt repayment			75,000		682,031
Interest paid	816,445				7,031																					$ 0
Loss on conversion			$ 2,450		47,373
June Two Thousand Twenty Four Notes [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument face amount		88,888			50,000	88,888
Conversion of debt into shares | shares				2,317
Price at which shares are converted | $ / shares				$ 3.38
Total amount of shares		$ 91,556		$ 7,838	$ 51,500	$ 91,556
Debt conversion converted instrument rate		103%			103%	103%
Senior Secured Convertible Promissory Note [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument face amount										$ 800,000
Senior Secured Convertible Promissory Note [Member] | October 2023 SPA [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument face amount																												$ 2,000,000
Price at which shares are converted | $ / shares																												$ 24
Exercise price of warrants or rights | $ / shares																												$ 24
Warrants to purchase | shares																						22,279						43,336
Aggregate relative fair value																						$ 98,708						$ 332,630
Senior Secured Convertible Promissory Note [Member] | June 2024 SPA [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument face amount								$ 400,000
2022 Equity Incentive Plan [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock based compensation																																									753,188	$ 440,219
Share based compensation, unrecognized expense	$ 311,593																																								$ 311,593
Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares																																				35,000
Common stock par value | $ / shares																																				$ 43
Issuance of shares, value																																				$ 1,505,000
Share price | $ / shares	$ 3.32																																								$ 3.32
First Tranche [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares												17,576								119,796
Price at which shares are converted | $ / shares												$ 12.60								$ 4.80
Total amount of shares												$ 221,449								$ 574,779
First Tranche [Member] | Convertible Notes Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument face amount													750,000		125,000		125,000			625,000
Gain on extinguishment of debt													131,165		180,566		20,547			391,447
Total amount of shares													$ 772,500		$ 128,750		$ 128,750			$ 643,750
Debt conversion converted instrument rate													103%
First Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price | $ / shares																							$ 11
First Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Exercise Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price | $ / shares																							$ 26.40
First Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term																							5 years
First Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Option Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected volatility rate																							137.10%
First Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Dividend Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividend rate																							0%
First Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Discount Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Discount rate																							4.72
First Tranche [Member] | Senior Secured Convertible Promissory Note [Member] | October 2023 SPA [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase | shares																							4,167
Aggregate relative fair value																							$ 38,029
Second Tranche [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Conversion of debt into shares | shares																		94,417	94,417
Price at which shares are converted | $ / shares																		$ 3.60	$ 3.40
Gain on extinguishment of debt																		$ 64,334	$ 48,094
Total amount of shares																		339,334	323,094
Second Tranche [Member] | Convertible Notes Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Debt instrument face amount																		275,000	275,000
Total amount of shares																		$ 283,250	$ 283,250
Debt conversion converted instrument rate																		103%	103%
Second Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Share Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Share price | $ / shares																						$ 6.40	$ 6.40
Second Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Exercise Price [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Exercise price | $ / shares																						$ 10	$ 11
Second Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Term [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected term																						5 years	5 years
Second Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Option Volatility [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected volatility rate																						137.10%	137.10%
Second Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Expected Dividend Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Expected dividend rate																						0%	0%
Second Tranche [Member] | Convertible Notes Payable [Member] | October 2023 SPA [Member] | Measurement Input, Discount Rate [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Discount rate																						3.93	3.93
Second Tranche [Member] | Senior Secured Convertible Promissory Note [Member] | October 2023 SPA [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Warrants to purchase | shares																						22,279	2,750
Aggregate relative fair value																						$ 98,708	$ 14,753
Upon Signing [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash payment							50,000
After Thirty Days [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash payment							$ 50,000
Share-Based Payment Arrangement, Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Options exercise price | $ / shares	$ 10.46																									$ 10.46															$ 10.46	$ 10.46
Consultants [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock based compensation																																					$ 25,000
Value of stock issued																																$ 121,000		$ 88,000	$ 52,500
Consultants [Member] | Marketing Services Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares														50,000
Number of shares issued | shares									30,000					50,000		5,000
Value of stock issued									$ 220,800					$ 368,000		$ 10,500
Share price | $ / shares									$ 7.40					$ 7.40		$ 2.20
Cash payment														$ 100,000																								$ 30,000
Mr Frank Ingriselli [Member] | Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares																															10,000
Common stock par value | $ / shares																															$ 21.40
Issuance of shares, value																															$ 213,000
Four Outside Director [Member] | Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares																													21,250
Common stock par value | $ / shares																													$ 0.0001
Stock based compensation																																									$ 177,259	$ 96,016
Issuance of shares, value																													$ 273,275
Share price | $ / shares																													$ 12.80
Investors [Member] | April 2024 Debt Financing [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares										37,500	37,500
Issuance of shares, value										$ 301,500	$ 366,000
Price at which shares are converted | $ / shares										$ 8	$ 9.80
Consultant [Member] | Share-Based Payment Arrangement, Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued | shares																														6,000
Options exercise price | $ / shares																														$ 10.46
Number of options vesting period																														24 months
Number of options granted fair value																														$ 55,711
IPO [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Issuance of common stock for cash, net, shares | shares																																							18,750
Gross proceeds																																							$ 6,000,000
Common stock par value | $ / shares																																							$ 60
Number of shares sold | shares																																					100,000		100,000
Sale of stock, price per share | $ / shares																																					$ 60		$ 60
Percentage of outstanding principal balance																																							25%
Debt instrument face amount																																							$ 4,500,000
Over-Allotment Option [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Shares issued warrants to purchase | shares																																					5,000		5,000
Exercise price of warrants or rights | $ / shares																																					$ 66		$ 66
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, par value | $ / shares																																$ 0.0001		$ 0.0001	$ 0.0001					$ 0.0001
Issuance of common stock for cash, net, shares | shares							12,500																														625			20,000		20,000
Gross proceeds																																								$ 400,000
Common stock par value | $ / shares																																$ 24.20		$ 17.60	$ 42		$ 40			$ 20
Issuance of shares, value							$ 43,800																																			$ 2
Number of shares issued | shares																									10,000							5,000		5,000	1,250							14,275
Value of stock issued																																										$ 1
Common Stock [Member] | April 2024 Debt Financing [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Price at which shares are converted | $ / shares										$ 9.80
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, par value | $ / shares																													$ 0.0001
Issuance of common stock for cash, net, shares | shares																													21,250
Common stock par value | $ / shares																													$ 12.80
Issuance of shares, value																													$ 273,275
Common Stock [Member] | Consultants [Member] | Marketing Services Agreement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cash payment									$ 30,000
Common Stock [Member] | Marcum LLP [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, par value | $ / shares																																	$ 0.0001
Issuance of common stock for cash, net, shares | shares																																	2,400
Common stock par value | $ / shares																																	$ 33.40
Issuance of shares, value																																	$ 80,159
Common Stock [Member] | Vendor [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued | shares																									10,000
Value of stock issued																									$ 95,200
Share price | $ / shares																									$ 9.60
Common Stock [Member] | Two Accredited Investors [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of shares issued | shares																																								20,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Consulting Agreement [Member] - USD ($)	Jan. 02, 2025	Jan. 01, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Monthly compensation		$ 7,500
Stock issued during period shares restricted stock award gross		20,000
Chief Financial Officer [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Payments for Other Fees	$ 12,500